"Entry_Name","Uniprot_ID","Protein_Name","RBP2GO_Score","Nb_Datasets","Listing_Count","AVG10_Int_Listing_Count","Mass_kDa","Length_AA","pI","Gene_Name","Alias_Names","Only.with.poly.A..enrichment","Only.without.poly.A..enrichment","R.DeeP_HeLa","Cook_Database.Hs._2011","Baltz_HEK293_2012","Castello_HeLa.S3_2012","Ray_InVitro.Hs._2013","Gerstberger_Review_2014","Kramer_HeLa_2014","Beckmann_HuH.7_2015","Brannan_InSilico_2016","Castello_HeLa.S3_2016","Conrad_K562_2016","Hendrickson_K562_2016","Sundararaman_InSilico_2016","Mullari_HEK293_2017","Milek_MCF7_2017","Treiber_A549_2017","Treiber_DLD.1_2017","Treiber_DU145_2017","Treiber_HEPG2_2017","Treiber_Jurkat_2017","Treiber_LN.229_2017","Treiber_MCF7_2017","Treiber_NTERA.2_2017","Treiber_Raji_2017","Treiber_SK.MEL.28_2017","Treiber_SK.N.MC_2017","Bao_HeLa_2018","Huang_HeLa_2018","Perez.Perri_Jurkat_RIC_2018","Perez.Perri_Jurkat_eRIC_2018","Garcia.Moreno_HEK293_2019","GO_Consortium_RNA_Binding.Hs._2019","Mallam_HEK293_2019","Panhale_HEK293_2019","Queiroz_HEK293_2019","Queiroz_MCF10A_2019","Queiroz_U2OS_2019","Trendel_MCF7_2019","Trendel_HEK293_2019","Trendel_HeLa_2019","Urdaneta_HEK293_2019","Backlund_HuH.7_Cytoplasmic_2020","Backlund_HuH.7_Nuclear_2020","GO_BP","GO_MF","GO_CC","CGC_Listed","CGC_Tier","CGC_Dominant_Recessive","CGC_Oncogene","CGC_Tumor_Suppressor","CGC_Fusion","Disease_Involvement","InterPro","String_ID","String_PPI","String_PPI_Scores","GO_BP_Tree","GO_MF_Tree","GO_CC_Tree","Nb_Homologs","Nb_RBP_Homologs","List_Homologs","List_RBP_Homologs","Gene_Type"
"SYFM_HUMAN","O95363","Phenylalanine--tRNA ligase, mitochondrial",15.5,43,3,10.3,52.357,451,7.141,"FARS2","FARS2 FARS1 HSPC320"," "," "," "," "," "," "," ","X"," "," ","X"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ","X"," "," "," "," "," "," "," "," "," "," "," ","organic substance biosynthetic process [GO:1901576]; organonitrogen compound biosynthetic process [GO:1901566]; organonitrogen compound metabolic process [GO:1901564]; organic cyclic compound metabolic process [GO:1901360]; nucleic acid metabolic process [GO:0090304]; organic substance metabolic process [GO:0071704]; heterocycle metabolic process [GO:0046483]; small molecule metabolic process [GO:0044281]; cellular nitrogen compound biosynthetic process [GO:0044271]; cellular protein metabolic process [GO:0044267]; cellular macromolecule metabolic process [GO:0044260]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; amide biosynthetic process [GO:0043604]; cellular amide metabolic process [GO:0043603]; oxoacid metabolic process [GO:0043436]; macromolecule metabolic process [GO:0043170]; peptide biosynthetic process [GO:0043043]; tRNA aminoacylation [GO:0043039]; amino acid activation [GO:0043038]; ncRNA metabolic process [GO:0034660]; cellular macromolecule biosynthetic process [GO:0034645]; cellular nitrogen compound metabolic process [GO:0034641]; ncRNA processing [GO:0034470]; carboxylic acid metabolic process [GO:0019752]; protein metabolic process [GO:0019538]; RNA metabolic process [GO:0016070]; gene expression [GO:0010467]; cellular process [GO:0009987]; macromolecule biosynthetic process [GO:0009059]; biosynthetic process [GO:0009058]; metabolic process [GO:0008152]; biological_process [GO:0008150]; tRNA processing [GO:0008033]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; cellular amino acid metabolic process [GO:0006520]; peptide metabolic process [GO:0006518]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; translation [GO:0006412]; tRNA metabolic process [GO:0006399]; RNA processing [GO:0006396]; nucleobase-containing compound metabolic process [GO:0006139]; organic acid metabolic process [GO:0006082]","heterocyclic compound binding [GO:1901363]; nucleoside phosphate binding [GO:1901265]; catalytic activity, acting on a tRNA [GO:0140101]; catalytic activity, acting on RNA [GO:0140098]; carbohydrate derivative binding [GO:0097367]; organic cyclic compound binding [GO:0097159]; anion binding [GO:0043168]; ion binding [GO:0043167]; small molecule binding [GO:0036094]; purine ribonucleoside triphosphate binding [GO:0035639]; adenyl ribonucleotide binding [GO:0032559]; purine ribonucleotide binding [GO:0032555]; ribonucleotide binding [GO:0032553]; adenyl nucleotide binding [GO:0030554]; purine nucleotide binding [GO:0017076]; ligase activity, forming carbon-oxygen bonds [GO:0016875]; ligase activity [GO:0016874]; drug binding [GO:0008144]; ATP binding [GO:0005524]; binding [GO:0005488]; phenylalanine-tRNA ligase activity [GO:0004826]; aminoacyl-tRNA ligase activity [GO:0004812]; catalytic activity [GO:0003824]; RNA binding [GO:0003723]; nucleic acid binding [GO:0003676]; molecular_function [GO:0003674]; nucleotide binding [GO:0000166]; tRNA binding [GO:0000049]","intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete mitochondrial part [GO:0044429]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; membrane-enclosed lumen [GO:0031974]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]"," ",NA," ",NA,NA,NA,"Combined oxidative phosphorylation deficiency 14 (COXPD14) [MIM:614946]: A severe multisystemic autosomal recessive disorder characterized by neonatal onset of global developmental delay, refractory seizures, and lactic acidosis. Biochemical studies show deficiencies of multiple mitochondrial respiratory enzymes. {ECO:0000269|PubMed:22499341, ECO:0000269|PubMed:22833457}. The disease is caused by mutations affecting the gene represented in this entry.; Spastic paraplegia 77, autosomal recessive (SPG77) [MIM:617046]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:26553276}. The disease is caused by mutations affecting the gene represented in this entry.","Aminoacyl-tRNA synthetase, class II [IPR006195]; Ferrodoxin-fold anticodon-binding domain [IPR005121]; Ferrodoxin-fold anticodon-binding domain superfamily [IPR036690]; Phenylalanyl-tRNA synthetase, class IIc, mitochondrial [IPR004530]; Phenylalanyl-tRNA synthetase [IPR002319]","9606.ENSP00000316335","Q9NSD9; P54577; Q15031; Q9Y2Z4; Q9Y285; Q5T160; P49588; P26640; Q9NSE4; Q96GW9; Q96I59; Q5ST30; P49591; Q15046; Q9NP81; A2RTX5; P26639; Q9UGM6; Q5JPH6; Q9P2J5; Q7L3T8; P41252; Q9BW92; P56192; Q5JTZ9; Q8N1G4; Q6PI48; O43776; P00966; P23381; P12081; P47897; P41250; P07814; P49590; P68104; Q9HD34; P49589; Q8TBF4; Q9NPF2","987; 935; 909; 909; 895; 889; 875; 874; 872; 866; 866; 865; 862; 861; 860; 858; 856; 854; 853; 849; 847; 841; 829; 814; 808; 803; 801; 795; 775; 774; 757; 752; 747; 741; 723; 718; 707; 678; 670; 644","organic substance biosynthetic process [GO:1901576]; organonitrogen compound biosynthetic process [GO:1901566]; organonitrogen compound metabolic process [GO:1901564]; organic cyclic compound metabolic process [GO:1901360]; nucleic acid metabolic process [GO:0090304]; organic substance metabolic process [GO:0071704]; heterocycle metabolic process [GO:0046483]; small molecule metabolic process [GO:0044281]; cellular nitrogen compound biosynthetic process [GO:0044271]; cellular protein metabolic process [GO:0044267]; cellular macromolecule metabolic process [GO:0044260]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; amide biosynthetic process [GO:0043604]; cellular amide metabolic process [GO:0043603]; oxoacid metabolic process [GO:0043436]; macromolecule metabolic process [GO:0043170]; peptide biosynthetic process [GO:0043043]; tRNA aminoacylation [GO:0043039]; amino acid activation [GO:0043038]; ncRNA metabolic process [GO:0034660]; cellular macromolecule biosynthetic process [GO:0034645]; cellular nitrogen compound metabolic process [GO:0034641]; ncRNA processing [GO:0034470]; carboxylic acid metabolic process [GO:0019752]; protein metabolic process [GO:0019538]; RNA metabolic process [GO:0016070]; gene expression [GO:0010467]; cellular process [GO:0009987]; macromolecule biosynthetic process [GO:0009059]; biosynthetic process [GO:0009058]; metabolic process [GO:0008152]; biological_process [GO:0008150]; tRNA processing [GO:0008033]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; cellular amino acid metabolic process [GO:0006520]; peptide metabolic process [GO:0006518]; phenylalanyl-tRNA aminoacylation [GO:0006432]; tRNA aminoacylation for protein translation [GO:0006418]; translation [GO:0006412]; tRNA metabolic process [GO:0006399]; RNA processing [GO:0006396]; nucleobase-containing compound metabolic process [GO:0006139]; organic acid metabolic process [GO:0006082]","heterocyclic compound binding [GO:1901363]; nucleoside phosphate binding [GO:1901265]; catalytic activity, acting on a tRNA [GO:0140101]; catalytic activity, acting on RNA [GO:0140098]; carbohydrate derivative binding [GO:0097367]; organic cyclic compound binding [GO:0097159]; anion binding [GO:0043168]; ion binding [GO:0043167]; small molecule binding [GO:0036094]; purine ribonucleoside triphosphate binding [GO:0035639]; adenyl ribonucleotide binding [GO:0032559]; purine ribonucleotide binding [GO:0032555]; ribonucleotide binding [GO:0032553]; adenyl nucleotide binding [GO:0030554]; purine nucleotide binding [GO:0017076]; ligase activity, forming carbon-oxygen bonds [GO:0016875]; ligase activity [GO:0016874]; drug binding [GO:0008144]; ATP binding [GO:0005524]; binding [GO:0005488]; phenylalanine-tRNA ligase activity [GO:0004826]; aminoacyl-tRNA ligase activity [GO:0004812]; catalytic activity [GO:0003824]; RNA binding [GO:0003723]; nucleic acid binding [GO:0003676]; molecular_function [GO:0003674]; nucleotide binding [GO:0000166]; tRNA binding [GO:0000049]","intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete mitochondrial part [GO:0044429]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; membrane-enclosed lumen [GO:0031974]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]",0,0,"","","Overlapped"
"GEMI8_HUMAN","Q9NWZ8","Gem-associated protein 8",14.2,43,2,10.2,28.637,242,6.471,"GEMIN8","GEMIN8 FAM51A1"," "," "," "," "," "," "," ","X"," "," ","X"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ","organic cyclic compound metabolic process [GO:1901360]; nucleic acid metabolic process [GO:0090304]; cellular component organization or biogenesis [GO:0071840]; ribonucleoprotein complex subunit organization [GO:0071826]; organic substance metabolic process [GO:0071704]; protein-containing complex assembly [GO:0065003]; establishment of localization in cell [GO:0051649]; cellular localization [GO:0051641]; establishment of localization [GO:0051234]; localization [GO:0051179]; import into nucleus [GO:0051170]; nuclear transport [GO:0051169]; intracellular transport [GO:0046907]; heterocycle metabolic process [GO:0046483]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; cellular component biogenesis [GO:0044085]; protein-containing complex subunit organization [GO:0043933]; macromolecule metabolic process [GO:0043170]; cellular nitrogen compound metabolic process [GO:0034641]; cellular protein-containing complex assembly [GO:0034622]; ribonucleoprotein complex assembly [GO:0022618]; ribonucleoprotein complex biogenesis [GO:0022613]; cellular component assembly [GO:0022607]; mRNA metabolic process [GO:0016071]; RNA metabolic process [GO:0016070]; cellular component organization [GO:0016043]; gene expression [GO:0010467]; cellular process [GO:0009987]; RNA splicing [GO:0008380]; metabolic process [GO:0008152]; biological_process [GO:0008150]; nucleocytoplasmic transport [GO:0006913]; transport [GO:0006810]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]; nucleobase-containing compound metabolic process [GO:0006139]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]; RNA splicing, via transesterification reactions with bulged adenosine as nucleophile [GO:0000377]; RNA splicing, via transesterification reactions [GO:0000375]","","Sm-like protein family complex [GO:0120114]; Gemini of coiled bodies [GO:0097504]; intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete nucleoplasm part [GO:0044451]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete nuclear part [GO:0044428]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; SMN-Sm protein complex [GO:0034719]; protein-containing complex [GO:0032991]; SMN complex [GO:0032797]; nuclear lumen [GO:0031981]; membrane-enclosed lumen [GO:0031974]; nuclear body [GO:0016604]; cytosol [GO:0005829]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]"," ",NA," ",NA,NA,NA,"","Gemini of Cajal bodies-associated protein 8 [IPR034754]","9606.ENSP00000369895","O14893; Q8WXD5; Q9H840; Q9UHI6; Q9Y3F4; Q16637; Q8TEQ6; P57678; P62304; P62306; P62314; P62308; Q96RS0; Q99567; Q92621; Q9H814; O75312; P49790; P57740; P37198; P62318; P14678; O14744; Q09161; P62316; P78406; O95149; Q9BQA1; P54105; Q8NFH4; Q9BTX1; Q8NFH3; P52298; Q8NFH5; Q7Z3B4; O15504; Q9UKX7; O75694; Q9BW27; Q9NRG9","997; 997; 996; 994; 993; 992; 988; 978; 958; 955; 954; 952; 943; 938; 938; 936; 934; 929; 929; 924; 922; 921; 920; 915; 913; 909; 906; 906; 905; 902; 902; 902; 902; 902; 902; 902; 901; 901; 900; 900","organic cyclic compound metabolic process [GO:1901360]; nucleic acid metabolic process [GO:0090304]; cellular component organization or biogenesis [GO:0071840]; ribonucleoprotein complex subunit organization [GO:0071826]; organic substance metabolic process [GO:0071704]; protein-containing complex assembly [GO:0065003]; establishment of localization in cell [GO:0051649]; cellular localization [GO:0051641]; establishment of localization [GO:0051234]; localization [GO:0051179]; import into nucleus [GO:0051170]; nuclear transport [GO:0051169]; intracellular transport [GO:0046907]; heterocycle metabolic process [GO:0046483]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; cellular component biogenesis [GO:0044085]; protein-containing complex subunit organization [GO:0043933]; macromolecule metabolic process [GO:0043170]; cellular nitrogen compound metabolic process [GO:0034641]; cellular protein-containing complex assembly [GO:0034622]; ribonucleoprotein complex assembly [GO:0022618]; ribonucleoprotein complex biogenesis [GO:0022613]; cellular component assembly [GO:0022607]; mRNA metabolic process [GO:0016071]; RNA metabolic process [GO:0016070]; cellular component organization [GO:0016043]; gene expression [GO:0010467]; cellular process [GO:0009987]; RNA splicing [GO:0008380]; metabolic process [GO:0008152]; biological_process [GO:0008150]; nucleocytoplasmic transport [GO:0006913]; transport [GO:0006810]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]; nucleobase-containing compound metabolic process [GO:0006139]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]; RNA splicing, via transesterification reactions with bulged adenosine as nucleophile [GO:0000377]; RNA splicing, via transesterification reactions [GO:0000375]","","Sm-like protein family complex [GO:0120114]; Gemini of coiled bodies [GO:0097504]; intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete nucleoplasm part [GO:0044451]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete nuclear part [GO:0044428]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; SMN-Sm protein complex [GO:0034719]; protein-containing complex [GO:0032991]; SMN complex [GO:0032797]; nuclear lumen [GO:0031981]; membrane-enclosed lumen [GO:0031974]; nuclear body [GO:0016604]; cytosol [GO:0005829]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]",0,0,"","","Overlapped"
"AK1BF_HUMAN","C9JRZ8","Aldo-keto reductase family 1 member B15",7.9,43,1,5.8,36.537,316,6.387,"AKR1B15","AKR1B15"," "," "," "," "," "," "," "," "," "," ","X"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ","organic substance biosynthetic process [GO:1901576]; organic cyclic compound biosynthetic process [GO:1901362]; organic cyclic compound metabolic process [GO:1901360]; organic substance metabolic process [GO:0071704]; regulation of biological quality [GO:0065008]; biological regulation [GO:0065007]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; hormone biosynthetic process [GO:0042446]; hormone metabolic process [GO:0042445]; cellular hormone metabolic process [GO:0034754]; regulation of hormone levels [GO:0010817]; cellular process [GO:0009987]; biosynthetic process [GO:0009058]; lipid biosynthetic process [GO:0008610]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; metabolic process [GO:0008152]; biological_process [GO:0008150]; estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]; lipid metabolic process [GO:0006629]","NADP-retinol dehydrogenase activity [GO:0052650]; farnesol dehydrogenase activity [GO:0047886]; allyl-alcohol dehydrogenase activity [GO:0047655]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0033764]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; aldo-keto reductase (NADP) activity [GO:0004033]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; catalytic activity [GO:0003824]; molecular_function [GO:0003674]","intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete mitochondrial part [GO:0044429]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; membrane-enclosed lumen [GO:0031974]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]"," ",NA," ",NA,NA,NA,"","Aldo/keto reductase, conserved site [IPR018170]; Aldo/keto reductase [IPR020471]; NADP-dependent oxidoreductase domain [IPR023210]; NADP-dependent oxidoreductase domain superfamily [IPR036812]","9606.ENSP00000389289","P09104; P22392; P31948; P49773; P06733; P15121; P29401; Q04760; O43448; Q13303; O60218; O43488; Q14722; O95154; Q00796; Q8NGX2; Q99714; Q3LXA3; O75191; P37837; P00441; Q9UQ10; Q9BT78; P48506; Q6S8J3; Q8TBY9; P22607; P30520; Q9H078; Q8NBN7; P22760; Q5JTJ3; O60812; O00764; Q01850; P04179; Q8N357; Q3KQV9; O60701; Q01804","889; 877; 835; 823; 731; 701; 650; 640; 596; 577; 528; 510; 498; 486; 478; 455; 452; 446; 424; 418; 417; 413; 404; 392; 385; 374; 367; 363; 357; 356; 356; 354; 351; 347; 347; 344; 341; 337; 336; 330","organic substance biosynthetic process [GO:1901576]; organic cyclic compound biosynthetic process [GO:1901362]; organic cyclic compound metabolic process [GO:1901360]; organic substance metabolic process [GO:0071704]; regulation of biological quality [GO:0065008]; biological regulation [GO:0065007]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; hormone biosynthetic process [GO:0042446]; hormone metabolic process [GO:0042445]; cellular hormone metabolic process [GO:0034754]; regulation of hormone levels [GO:0010817]; cellular process [GO:0009987]; biosynthetic process [GO:0009058]; lipid biosynthetic process [GO:0008610]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; metabolic process [GO:0008152]; biological_process [GO:0008150]; estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]; lipid metabolic process [GO:0006629]","NADP-retinol dehydrogenase activity [GO:0052650]; farnesol dehydrogenase activity [GO:0047886]; allyl-alcohol dehydrogenase activity [GO:0047655]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0033764]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; aldo-keto reductase (NADP) activity [GO:0004033]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; catalytic activity [GO:0003824]; molecular_function [GO:0003674]","intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete mitochondrial part [GO:0044429]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; membrane-enclosed lumen [GO:0031974]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]",4,0,"O60218; P45376; P21300; Q5TYY5","","Overlapped"
"DIAP2_HUMAN","O60879","Protein diaphanous homolog 2",7.3,43,1,5.3,125.569,1101,6.288,"DIAPH2","DIAPH2 DIA"," ","X",""," ","","","",""," ","","","","","","","",""," "," "," "," "," "," "," "," "," "," "," "," ",""," "," "," "," ",""," ","","",""," "," "," ","X","","","supramolecular fiber organization [GO:0097435]; cellular component organization or biogenesis [GO:0071840]; multi-organism process [GO:0051704]; cellular developmental process [GO:0048869]; anatomical structure development [GO:0048856]; multicellular organismal reproductive process [GO:0048609]; oogenesis [GO:0048477]; cell development [GO:0048468]; multi-organism reproductive process [GO:0044703]; multicellular organism reproduction [GO:0032504]; developmental process [GO:0032502]; multicellular organismal process [GO:0032501]; cell differentiation [GO:0030154]; actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; reproductive process [GO:0022414]; cellular process involved in reproduction in multicellular organism [GO:0022412]; sexual reproduction [GO:0019953]; cellular component organization [GO:0016043]; cellular process [GO:0009987]; biological_process [GO:0008150]; female gamete generation [GO:0007292]; germ cell development [GO:0007281]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; actin filament organization [GO:0007015]; cytoskeleton organization [GO:0007010]; organelle organization [GO:0006996]; developmental process involved in reproduction [GO:0003006]; reproduction [GO:0000003]","GTPase binding [GO:0051020]; small GTPase binding [GO:0031267]; enzyme binding [GO:0019899]; Rho GTPase binding [GO:0017048]; Ras GTPase binding [GO:0017016]; cytoskeletal protein binding [GO:0008092]; protein binding [GO:0005515]; binding [GO:0005488]; signaling receptor binding [GO:0005102]; actin binding [GO:0003779]; molecular_function [GO:0003674]","intracellular vesicle [GO:0097708]; intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete nuclear part [GO:0044428]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular non-membrane-bounded organelle [GO:0043232]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; non-membrane-bounded organelle [GO:0043228]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; vesicle [GO:0031982]; nuclear lumen [GO:0031981]; membrane-enclosed lumen [GO:0031974]; cytoplasmic vesicle [GO:0031410]; endomembrane system [GO:0012505]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; early endosome [GO:0005769]; endosome [GO:0005768]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]"," ",NA," ",NA,NA,NA,"Premature ovarian failure 2A (POF2A) [MIM:300511]: An ovarian disorder defined as the cessation of ovarian function under the age of 40 years. It is characterized by oligomenorrhea or amenorrhea, in the presence of elevated levels of serum gonadotropins and low estradiol. {ECO:0000269|PubMed:9497258}. The disease is caused by mutations affecting the gene represented in this entry.","Armadillo-like helical [IPR011989]; Armadillo-type fold [IPR016024]; Diaphanous autoregulatory (DAD) domain [IPR014767]; Protein diaphanous homologue 2 [IPR027644]; DRF autoregulatory [IPR010465]; Formin, FH2 domain [IPR015425]; Formin, FH2 domain superfamily [IPR042201]; Formin, FH3 domain [IPR010472]; Rho GTPase-binding/formin homology 3 (GBD/FH3) domain [IPR014768]; Formin, GTPase-binding domain [IPR010473]","9606.ENSP00000321348","P61586; P35080; P07737; Q8NHR9; P60673; O60610; Q9NSV4; O00212; Q8WVV4; Q06787; Q6RI45; P60953; P0C0E4; Q8NB49; P58012; P49335; Q96NX9; Q9UJ90; Q9BXU2; P08134; P29400; Q9Y462; Q8NEK8; O43895; Q5JUX0; Q8IZI9; Q6QHK4; P31949; P46100; O95972; P53004; Q6ZTR5; P62745; Q13464; Q13285; P00387; P60891; Q96RU3; Q4VCS5; Q9BPY3","931; 864; 863; 859; 810; 807; 805; 765; 726; 678; 675; 653; 643; 642; 626; 621; 617; 608; 604; 601; 590; 585; 563; 543; 528; 527; 527; 525; 511; 505; 504; 503; 475; 471; 469; 468; 464; 461; 460; 458","supramolecular fiber organization [GO:0097435]; cellular component organization or biogenesis [GO:0071840]; multi-organism process [GO:0051704]; cellular developmental process [GO:0048869]; anatomical structure development [GO:0048856]; multicellular organismal reproductive process [GO:0048609]; oogenesis [GO:0048477]; cell development [GO:0048468]; multi-organism reproductive process [GO:0044703]; multicellular organism reproduction [GO:0032504]; developmental process [GO:0032502]; multicellular organismal process [GO:0032501]; cell differentiation [GO:0030154]; actin cytoskeleton organization [GO:0030036]; actin filament-based process [GO:0030029]; reproductive process [GO:0022414]; cellular process involved in reproduction in multicellular organism [GO:0022412]; sexual reproduction [GO:0019953]; cellular component organization [GO:0016043]; cellular process [GO:0009987]; biological_process [GO:0008150]; female gamete generation [GO:0007292]; germ cell development [GO:0007281]; gamete generation [GO:0007276]; multicellular organism development [GO:0007275]; actin filament organization [GO:0007015]; cytoskeleton organization [GO:0007010]; organelle organization [GO:0006996]; developmental process involved in reproduction [GO:0003006]; reproduction [GO:0000003]","GTPase binding [GO:0051020]; small GTPase binding [GO:0031267]; enzyme binding [GO:0019899]; Rho GTPase binding [GO:0017048]; Ras GTPase binding [GO:0017016]; cytoskeletal protein binding [GO:0008092]; protein binding [GO:0005515]; binding [GO:0005488]; signaling receptor binding [GO:0005102]; actin binding [GO:0003779]; molecular_function [GO:0003674]","intracellular vesicle [GO:0097708]; intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete nuclear part [GO:0044428]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular non-membrane-bounded organelle [GO:0043232]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; non-membrane-bounded organelle [GO:0043228]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; vesicle [GO:0031982]; nuclear lumen [GO:0031981]; membrane-enclosed lumen [GO:0031974]; cytoplasmic vesicle [GO:0031410]; endomembrane system [GO:0012505]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; early endosome [GO:0005769]; endosome [GO:0005768]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]",1,0,"O70566","","Overlapped"
"ANK2_HUMAN","Q01484","Ankyrin-2",4.7,43,1,3,433.715,3957,4.909,"ANK2","ANK2 ANKB"," ","X",""," ","","","",""," ","","","","","","","",""," "," "," "," "," "," "," "," "," "," "," "," ",""," "," "," "," ",""," ","","",""," "," "," ","X","","","positive regulation of cation channel activity [GO:2001259]; regulation of cation channel activity [GO:2001257]; protein localization to cell periphery [GO:1990778]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of cation transmembrane transport [GO:1904064]; regulation of cation transmembrane transport [GO:1904062]; regulation of cardiac conduction [GO:1903779]; regulation of blood circulation [GO:1903522]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of actin filament-based movement [GO:1903115]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of potassium ion transmembrane transport [GO:1901379]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; ventricular cardiac muscle cell membrane repolarization [GO:0099625]; regulation of cardiac muscle cell membrane repolarization [GO:0099623]; cardiac muscle cell membrane repolarization [GO:0099622]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of SA node cell action potential [GO:0098907]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of action potential [GO:0098900]; inorganic ion homeostasis [GO:0098771]; inorganic cation transmembrane transport [GO:0098662]; inorganic ion transmembrane transport [GO:0098660]; import into cell [GO:0098657]; cation transmembrane transport [GO:0098655]; calcium ion transmembrane import into cytosol [GO:0097553]; regulation of muscle system process [GO:0090257]; regulation of heart rate by cardiac conduction [GO:0086091]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cell communication involved in cardiac conduction [GO:0086065]; membrane depolarization during SA node cell action potential [GO:0086046]; atrial cardiac muscle cell to AV node cell signaling [GO:0086026]; cell-cell signaling involved in cardiac conduction [GO:0086019]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]; SA node cell action potential [GO:0086015]; atrial cardiac muscle cell action potential [GO:0086014]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; ventricular cardiac muscle cell action potential [GO:0086005]; regulation of cardiac muscle cell contraction [GO:0086004]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle cell action potential [GO:0086001]; protein localization to plasma membrane [GO:0072659]; protein localization to membrane [GO:0072657]; divalent inorganic cation transport [GO:0072511]; divalent inorganic cation homeostasis [GO:0072507]; cellular divalent inorganic cation homeostasis [GO:0072503]; circulatory system development [GO:0072359]; cellular component organization or biogenesis [GO:0071840]; potassium ion transmembrane transport [GO:0071805]; nitrogen compound transport [GO:0071705]; organic substance metabolic process [GO:0071704]; organic substance transport [GO:0071702]; protein localization to endoplasmic reticulum [GO:0070972]; divalent metal ion transport [GO:0070838]; cellular macromolecule localization [GO:0070727]; calcium ion transmembrane transport [GO:0070588]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; actin-mediated cell contraction [GO:0070252]; regulation of molecular function [GO:0065009]; regulation of biological quality [GO:0065008]; biological regulation [GO:0065007]; cardiac conduction [GO:0061337]; muscle structure development [GO:0061061]; membrane organization [GO:0061024]; calcium ion transport into cytosol [GO:0060402]; cytosolic calcium ion transport [GO:0060401]; regulation of cellular localization [GO:0060341]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; regulation of membrane repolarization [GO:0060306]; regulation of macromolecule metabolic process [GO:0060255]; cardiac muscle contraction [GO:0060048]; heart contraction [GO:0060047]; regulation of cardiac muscle contraction [GO:0055117]; transmembrane transport [GO:0055085]; cellular chemical homeostasis [GO:0055082]; cation homeostasis [GO:0055080]; calcium ion homeostasis [GO:0055074]; metal ion homeostasis [GO:0055065]; muscle cell development [GO:0055001]; positive regulation of calcium ion transport [GO:0051928]; regulation of calcium ion transport [GO:0051924]; membrane depolarization [GO:0051899]; cellular response to stimulus [GO:0051716]; establishment of localization in cell [GO:0051649]; cellular localization [GO:0051641]; response to methylmercury [GO:0051597]; regulation of cytosolic calcium ion concentration [GO:0051480]; negative regulation of sequestering of calcium ion [GO:0051283]; regulation of sequestering of calcium ion [GO:0051282]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of cellular component movement [GO:0051270]; regulation of multicellular organismal process [GO:0051239]; maintenance of location [GO:0051235]; establishment of localization [GO:0051234]; release of sequestered calcium ion into cytosol [GO:0051209]; sequestering of calcium ion [GO:0051208]; localization [GO:0051179]; positive regulation of transport [GO:0051050]; regulation of transport [GO:0051049]; response to stimulus [GO:0050896]; protein stabilization [GO:0050821]; ion homeostasis [GO:0050801]; regulation of cellular process [GO:0050794]; regulation of biological process [GO:0050789]; chemical homeostasis [GO:0048878]; cellular developmental process [GO:0048869]; anatomical structure development [GO:0048856]; system development [GO:0048731]; anatomical structure formation involved in morphogenesis [GO:0048646]; negative regulation of cellular process [GO:0048523]; positive regulation of cellular process [GO:0048522]; negative regulation of biological process [GO:0048519]; positive regulation of biological process [GO:0048518]; animal organ development [GO:0048513]; cell development [GO:0048468]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; cell-cell junction organization [GO:0045216]; establishment of protein localization [GO:0045184]; positive regulation of molecular function [GO:0044093]; cellular component biogenesis [GO:0044085]; regulation of system process [GO:0044057]; positive regulation of ion transport [GO:0043270]; regulation of ion transport [GO:0043269]; positive regulation of potassium ion transport [GO:0043268]; regulation of potassium ion transport [GO:0043266]; macromolecule metabolic process [GO:0043170]; amide transport [GO:0042886]; muscle cell differentiation [GO:0042692]; homeostatic process [GO:0042592]; myelination [GO:0042552]; regulation of membrane potential [GO:0042391]; response to chemical [GO:0042221]; protein localization to T-tubule [GO:0036371]; protein localization to M-band [GO:0036309]; multicellular organismal signaling [GO:0035637]; intracellular signal transduction [GO:0035556]; positive regulation of ion transmembrane transport [GO:0034767]; regulation of ion transmembrane transport [GO:0034765]; positive regulation of transmembrane transport [GO:0034764]; regulation of transmembrane transport [GO:0034762]; cellular protein localization [GO:0034613]; protein localization to cell surface [GO:0034394]; cell junction organization [GO:0034330]; cell junction assembly [GO:0034329]; ion transmembrane transport [GO:0034220]; protein localization to organelle [GO:0033365]; T-tubule organization [GO:0033292]; macromolecule localization [GO:0033036]; cellular component morphogenesis [GO:0032989]; regulation of actin filament-based process [GO:0032970]; regulation of localization [GO:0032879]; developmental process [GO:0032502]; multicellular organismal process [GO:0032501]; positive regulation of ion transmembrane transporter activity [GO:0032414]; regulation of ion transmembrane transporter activity [GO:0032412]; positive regulation of transporter activity [GO:0032411]; regulation of transporter activity [GO:0032409]; myelin assembly [GO:0032288]; regulation of protein stability [GO:0031647]; paranodal junction assembly [GO:0030913]; cell differentiation [GO:0030154]; actin filament-based movement [GO:0030048]; actin filament-based process [GO:0030029]; cellular cation homeostasis [GO:0030003]; metal ion transport [GO:0030001]; signaling [GO:0023052]; regulation of signaling [GO:0023051]; regulation of transmembrane transporter activity [GO:0022898]; cellular component assembly [GO:0022607]; second-messenger-mediated signaling [GO:0019932]; cellular homeostasis [GO:0019725]; calcium-mediated signaling [GO:0019722]; regulation of metabolic process [GO:0019222]; vesicle-mediated transport [GO:0016192]; cellular component organization [GO:0016043]; peptide transport [GO:0015833]; monovalent inorganic cation transport [GO:0015672]; protein transport [GO:0015031]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; regulation of metal ion transport [GO:0010959]; cellular component assembly involved in morphogenesis [GO:0010927]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of cell communication [GO:0010646]; positive regulation of gene expression [GO:0010628]; positive regulation of macromolecule metabolic process [GO:0010604]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of gene expression [GO:0010468]; gene expression [GO:0010467]; endomembrane system organization [GO:0010256]; response to organic substance [GO:0010033]; cellular process [GO:0009987]; positive regulation of metabolic process [GO:0009893]; anatomical structure morphogenesis [GO:0009653]; axon ensheathment [GO:0008366]; metabolic process [GO:0008152]; biological_process [GO:0008150]; protein localization [GO:0008104]; regulation of heart contraction [GO:0008016]; blood circulation [GO:0008015]; heart development [GO:0007507]; nervous system development [GO:0007399]; multicellular organism development [GO:0007275]; ensheathment of neurons [GO:0007272]; cell-cell signaling [GO:0007267]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165]; cell communication [GO:0007154]; cell-cell junction assembly [GO:0007043]; plasma membrane organization [GO:0007009]; regulation of striated muscle contraction [GO:0006942]; striated muscle contraction [GO:0006941]; regulation of muscle contraction [GO:0006937]; muscle contraction [GO:0006936]; movement of cell or subcellular component [GO:0006928]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; cellular metal ion homeostasis [GO:0006875]; cellular calcium ion homeostasis [GO:0006874]; cellular ion homeostasis [GO:0006873]; calcium ion transport [GO:0006816]; potassium ion transport [GO:0006813]; cation transport [GO:0006812]; ion transport [GO:0006811]; transport [GO:0006810]; atrial septum development [GO:0003283]; cardiac septum development [GO:0003279]; cardiac atrium development [GO:0003230]; cardiac chamber development [GO:0003205]; heart process [GO:0003015]; circulatory system process [GO:0003013]; muscle system process [GO:0003012]; system process [GO:0003008]; regulation of heart rate [GO:0002027]; action potential [GO:0001508]","phosphorylation-dependent protein binding [GO:0140031]; modification-dependent protein binding [GO:0140030]; molecular adaptor activity [GO:0060090]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; protein kinase binding [GO:0019901]; kinase binding [GO:0019900]; enzyme binding [GO:0019899]; cytoskeletal protein binding [GO:0008092]; protein binding [GO:0005515]; binding [GO:0005488]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; molecular_function [GO:0003674]","obsolete plasma membrane bounded cell projection part [GO:0120038]; plasma membrane bounded cell projection [GO:0120025]; supramolecular fiber [GO:0099512]; supramolecular polymer [GO:0099081]; supramolecular complex [GO:0099080]; membrane microdomain [GO:0098857]; whole membrane [GO:0098805]; postsynapse [GO:0098794]; plasma membrane region [GO:0098590]; membrane region [GO:0098589]; intracellular vesicle [GO:0097708]; obsolete neuron part [GO:0097458]; synaptic membrane [GO:0097060]; cell periphery [GO:0071944]; recycling endosome [GO:0055037]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; apical part of cell [GO:0045177]; membrane raft [GO:0045121]; obsolete cell part [GO:0044464]; obsolete cell projection part [GO:0044463]; obsolete plasma membrane part [GO:0044459]; obsolete synapse part [GO:0044456]; obsolete contractile fiber part [GO:0044449]; obsolete cytoplasmic part [GO:0044444]; obsolete membrane part [GO:0044425]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; main axon [GO:0044304]; cell-cell contact zone [GO:0044291]; contractile fiber [GO:0043292]; intracellular non-membrane-bounded organelle [GO:0043232]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; non-membrane-bounded organelle [GO:0043228]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; axon initial segment [GO:0043194]; costamere [GO:0043034]; neuron projection [GO:0043005]; cell projection [GO:0042995]; sarcolemma [GO:0042383]; obsolete axon part [GO:0033267]; vesicle [GO:0031982]; I band [GO:0031674]; A band [GO:0031672]; M band [GO:0031430]; cytoplasmic vesicle [GO:0031410]; axon [GO:0030424]; T-tubule [GO:0030315]; cell junction [GO:0030054]; Z disc [GO:0030018]; sarcomere [GO:0030017]; myofibril [GO:0030016]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; intercalated disc [GO:0014704]; endomembrane system [GO:0012505]; cell-cell junction [GO:0005911]; plasma membrane [GO:0005886]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; vacuole [GO:0005773]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]; lytic vacuole [GO:0000323]"," ",NA," ",NA,NA,NA,"Long QT syndrome 4 (LQT4) [MIM:600919]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. Long QT syndrome type 4 shows many atypical features compared to classical long QT syndromes, including pronounced sinus bradycardia, polyphasic T waves and atrial fibrillation. Cardiac repolarization defects may be not as severe as in classical LQT syndromes and prolonged QT interval on EKG is not a consistent feature. {ECO:0000269|PubMed:12571597, ECO:0000269|PubMed:15178757, ECO:0000269|PubMed:17940615}. The disease is caused by mutations affecting the gene represented in this entry.","Ankyrin repeat [IPR002110]; Ankyrin repeat-containing domain [IPR020683]; Ankyrin repeat-containing domain superfamily [IPR036770]; Ankyrin, UPA domain [IPR040745]; Death-like domain superfamily [IPR011029]; Death domain [IPR000488]; ZU5 domain [IPR000906]","9606.ENSP00000349588","Q92823; Q01082; O94856; Q14524; Q8IWT1; Q13813; P32004; Q99250; Q9UJW0; O95166; Q14571; Q9H254; Q9UQD0; P35498; Q14573; Q07699; O15020; O43526; P47756; Q9NY72; Q14643; O43525; O60939; P11277; Q9Y5Y9; Q9NRC6; Q9NY46; P35499; P02549; P84077; Q15858; Q14203; Q9UI33; O14576; P18085; Q12955; P84085; O60763; Q14204; P61204","984; 983; 982; 975; 973; 969; 969; 964; 962; 962; 961; 958; 956; 952; 950; 949; 948; 948; 947; 946; 944; 941; 935; 934; 934; 934; 934; 925; 924; 923; 923; 922; 917; 916; 915; 915; 915; 914; 914; 914","positive regulation of cation channel activity [GO:2001259]; regulation of cation channel activity [GO:2001257]; protein localization to cell periphery [GO:1990778]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of cation transmembrane transport [GO:1904064]; regulation of cation transmembrane transport [GO:1904062]; regulation of cardiac conduction [GO:1903779]; regulation of blood circulation [GO:1903522]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; regulation of calcium ion transmembrane transport [GO:1903169]; regulation of actin filament-based movement [GO:1903115]; positive regulation of potassium ion transmembrane transport [GO:1901381]; regulation of potassium ion transmembrane transport [GO:1901379]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; ventricular cardiac muscle cell membrane repolarization [GO:0099625]; regulation of cardiac muscle cell membrane repolarization [GO:0099623]; cardiac muscle cell membrane repolarization [GO:0099622]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of SA node cell action potential [GO:0098907]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of action potential [GO:0098900]; inorganic ion homeostasis [GO:0098771]; inorganic cation transmembrane transport [GO:0098662]; inorganic ion transmembrane transport [GO:0098660]; import into cell [GO:0098657]; cation transmembrane transport [GO:0098655]; calcium ion transmembrane import into cytosol [GO:0097553]; regulation of muscle system process [GO:0090257]; regulation of heart rate by cardiac conduction [GO:0086091]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; cell communication involved in cardiac conduction [GO:0086065]; membrane depolarization during SA node cell action potential [GO:0086046]; atrial cardiac muscle cell to AV node cell signaling [GO:0086026]; cell-cell signaling involved in cardiac conduction [GO:0086019]; SA node cell to atrial cardiac muscle cell signaling [GO:0086018]; SA node cell action potential [GO:0086015]; atrial cardiac muscle cell action potential [GO:0086014]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane depolarization during action potential [GO:0086010]; membrane repolarization [GO:0086009]; ventricular cardiac muscle cell action potential [GO:0086005]; regulation of cardiac muscle cell contraction [GO:0086004]; cardiac muscle cell contraction [GO:0086003]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cardiac muscle cell action potential [GO:0086001]; protein localization to plasma membrane [GO:0072659]; protein localization to membrane [GO:0072657]; divalent inorganic cation transport [GO:0072511]; divalent inorganic cation homeostasis [GO:0072507]; cellular divalent inorganic cation homeostasis [GO:0072503]; circulatory system development [GO:0072359]; cellular component organization or biogenesis [GO:0071840]; potassium ion transmembrane transport [GO:0071805]; nitrogen compound transport [GO:0071705]; organic substance metabolic process [GO:0071704]; organic substance transport [GO:0071702]; protein localization to endoplasmic reticulum [GO:0070972]; divalent metal ion transport [GO:0070838]; cellular macromolecule localization [GO:0070727]; calcium ion transmembrane transport [GO:0070588]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; actin-mediated cell contraction [GO:0070252]; regulation of molecular function [GO:0065009]; regulation of biological quality [GO:0065008]; biological regulation [GO:0065007]; cardiac conduction [GO:0061337]; muscle structure development [GO:0061061]; membrane organization [GO:0061024]; calcium ion transport into cytosol [GO:0060402]; cytosolic calcium ion transport [GO:0060401]; regulation of cellular localization [GO:0060341]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; regulation of membrane repolarization [GO:0060306]; regulation of macromolecule metabolic process [GO:0060255]; cardiac muscle contraction [GO:0060048]; heart contraction [GO:0060047]; regulation of cardiac muscle contraction [GO:0055117]; transmembrane transport [GO:0055085]; cellular chemical homeostasis [GO:0055082]; cation homeostasis [GO:0055080]; calcium ion homeostasis [GO:0055074]; metal ion homeostasis [GO:0055065]; muscle cell development [GO:0055001]; positive regulation of calcium ion transport [GO:0051928]; regulation of calcium ion transport [GO:0051924]; membrane depolarization [GO:0051899]; cellular response to stimulus [GO:0051716]; establishment of localization in cell [GO:0051649]; cellular localization [GO:0051641]; response to methylmercury [GO:0051597]; regulation of cytosolic calcium ion concentration [GO:0051480]; negative regulation of sequestering of calcium ion [GO:0051283]; regulation of sequestering of calcium ion [GO:0051282]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of cellular component movement [GO:0051270]; regulation of multicellular organismal process [GO:0051239]; maintenance of location [GO:0051235]; establishment of localization [GO:0051234]; release of sequestered calcium ion into cytosol [GO:0051209]; sequestering of calcium ion [GO:0051208]; localization [GO:0051179]; positive regulation of transport [GO:0051050]; regulation of transport [GO:0051049]; response to stimulus [GO:0050896]; protein stabilization [GO:0050821]; ion homeostasis [GO:0050801]; regulation of cellular process [GO:0050794]; regulation of biological process [GO:0050789]; chemical homeostasis [GO:0048878]; cellular developmental process [GO:0048869]; anatomical structure development [GO:0048856]; system development [GO:0048731]; anatomical structure formation involved in morphogenesis [GO:0048646]; negative regulation of cellular process [GO:0048523]; positive regulation of cellular process [GO:0048522]; negative regulation of biological process [GO:0048519]; positive regulation of biological process [GO:0048518]; animal organ development [GO:0048513]; cell development [GO:0048468]; Golgi vesicle transport [GO:0048193]; intracellular transport [GO:0046907]; cell-cell junction organization [GO:0045216]; establishment of protein localization [GO:0045184]; positive regulation of molecular function [GO:0044093]; cellular component biogenesis [GO:0044085]; regulation of system process [GO:0044057]; positive regulation of ion transport [GO:0043270]; regulation of ion transport [GO:0043269]; positive regulation of potassium ion transport [GO:0043268]; regulation of potassium ion transport [GO:0043266]; macromolecule metabolic process [GO:0043170]; amide transport [GO:0042886]; muscle cell differentiation [GO:0042692]; homeostatic process [GO:0042592]; myelination [GO:0042552]; regulation of membrane potential [GO:0042391]; response to chemical [GO:0042221]; protein localization to T-tubule [GO:0036371]; protein localization to M-band [GO:0036309]; multicellular organismal signaling [GO:0035637]; intracellular signal transduction [GO:0035556]; positive regulation of ion transmembrane transport [GO:0034767]; regulation of ion transmembrane transport [GO:0034765]; positive regulation of transmembrane transport [GO:0034764]; regulation of transmembrane transport [GO:0034762]; cellular protein localization [GO:0034613]; protein localization to cell surface [GO:0034394]; cell junction organization [GO:0034330]; cell junction assembly [GO:0034329]; ion transmembrane transport [GO:0034220]; protein localization to organelle [GO:0033365]; T-tubule organization [GO:0033292]; macromolecule localization [GO:0033036]; cellular component morphogenesis [GO:0032989]; regulation of actin filament-based process [GO:0032970]; regulation of localization [GO:0032879]; developmental process [GO:0032502]; multicellular organismal process [GO:0032501]; positive regulation of ion transmembrane transporter activity [GO:0032414]; regulation of ion transmembrane transporter activity [GO:0032412]; positive regulation of transporter activity [GO:0032411]; regulation of transporter activity [GO:0032409]; myelin assembly [GO:0032288]; regulation of protein stability [GO:0031647]; paranodal junction assembly [GO:0030913]; cell differentiation [GO:0030154]; actin filament-based movement [GO:0030048]; actin filament-based process [GO:0030029]; cellular cation homeostasis [GO:0030003]; metal ion transport [GO:0030001]; signaling [GO:0023052]; regulation of signaling [GO:0023051]; regulation of transmembrane transporter activity [GO:0022898]; cellular component assembly [GO:0022607]; second-messenger-mediated signaling [GO:0019932]; cellular homeostasis [GO:0019725]; calcium-mediated signaling [GO:0019722]; regulation of metabolic process [GO:0019222]; vesicle-mediated transport [GO:0016192]; cellular component organization [GO:0016043]; peptide transport [GO:0015833]; monovalent inorganic cation transport [GO:0015672]; protein transport [GO:0015031]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; regulation of metal ion transport [GO:0010959]; cellular component assembly involved in morphogenesis [GO:0010927]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of cell communication [GO:0010646]; positive regulation of gene expression [GO:0010628]; positive regulation of macromolecule metabolic process [GO:0010604]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of gene expression [GO:0010468]; gene expression [GO:0010467]; endomembrane system organization [GO:0010256]; response to organic substance [GO:0010033]; cellular process [GO:0009987]; positive regulation of metabolic process [GO:0009893]; anatomical structure morphogenesis [GO:0009653]; axon ensheathment [GO:0008366]; metabolic process [GO:0008152]; biological_process [GO:0008150]; protein localization [GO:0008104]; regulation of heart contraction [GO:0008016]; blood circulation [GO:0008015]; heart development [GO:0007507]; nervous system development [GO:0007399]; multicellular organism development [GO:0007275]; ensheathment of neurons [GO:0007272]; cell-cell signaling [GO:0007267]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal transduction [GO:0007165]; cell communication [GO:0007154]; cell-cell junction assembly [GO:0007043]; plasma membrane organization [GO:0007009]; regulation of striated muscle contraction [GO:0006942]; striated muscle contraction [GO:0006941]; regulation of muscle contraction [GO:0006937]; muscle contraction [GO:0006936]; movement of cell or subcellular component [GO:0006928]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; cellular metal ion homeostasis [GO:0006875]; cellular calcium ion homeostasis [GO:0006874]; cellular ion homeostasis [GO:0006873]; calcium ion transport [GO:0006816]; potassium ion transport [GO:0006813]; cation transport [GO:0006812]; ion transport [GO:0006811]; transport [GO:0006810]; atrial septum development [GO:0003283]; cardiac septum development [GO:0003279]; cardiac atrium development [GO:0003230]; cardiac chamber development [GO:0003205]; heart process [GO:0003015]; circulatory system process [GO:0003013]; muscle system process [GO:0003012]; system process [GO:0003008]; regulation of heart rate [GO:0002027]; action potential [GO:0001508]","phosphorylation-dependent protein binding [GO:0140031]; modification-dependent protein binding [GO:0140030]; molecular adaptor activity [GO:0060090]; ATPase binding [GO:0051117]; ion channel binding [GO:0044325]; protein-macromolecule adaptor activity [GO:0030674]; spectrin binding [GO:0030507]; protein kinase binding [GO:0019901]; kinase binding [GO:0019900]; enzyme binding [GO:0019899]; cytoskeletal protein binding [GO:0008092]; protein binding [GO:0005515]; binding [GO:0005488]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; molecular_function [GO:0003674]","obsolete plasma membrane bounded cell projection part [GO:0120038]; plasma membrane bounded cell projection [GO:0120025]; supramolecular fiber [GO:0099512]; supramolecular polymer [GO:0099081]; supramolecular complex [GO:0099080]; membrane microdomain [GO:0098857]; whole membrane [GO:0098805]; postsynapse [GO:0098794]; plasma membrane region [GO:0098590]; membrane region [GO:0098589]; intracellular vesicle [GO:0097708]; obsolete neuron part [GO:0097458]; synaptic membrane [GO:0097060]; cell periphery [GO:0071944]; recycling endosome [GO:0055037]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; apical part of cell [GO:0045177]; membrane raft [GO:0045121]; obsolete cell part [GO:0044464]; obsolete cell projection part [GO:0044463]; obsolete plasma membrane part [GO:0044459]; obsolete synapse part [GO:0044456]; obsolete contractile fiber part [GO:0044449]; obsolete cytoplasmic part [GO:0044444]; obsolete membrane part [GO:0044425]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; main axon [GO:0044304]; cell-cell contact zone [GO:0044291]; contractile fiber [GO:0043292]; intracellular non-membrane-bounded organelle [GO:0043232]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; non-membrane-bounded organelle [GO:0043228]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; axon initial segment [GO:0043194]; costamere [GO:0043034]; neuron projection [GO:0043005]; cell projection [GO:0042995]; sarcolemma [GO:0042383]; obsolete axon part [GO:0033267]; vesicle [GO:0031982]; I band [GO:0031674]; A band [GO:0031672]; M band [GO:0031430]; cytoplasmic vesicle [GO:0031410]; axon [GO:0030424]; T-tubule [GO:0030315]; cell junction [GO:0030054]; Z disc [GO:0030018]; sarcomere [GO:0030017]; myofibril [GO:0030016]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; intercalated disc [GO:0014704]; endomembrane system [GO:0012505]; cell-cell junction [GO:0005911]; plasma membrane [GO:0005886]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; vacuole [GO:0005773]; early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]; lytic vacuole [GO:0000323]",1,1,"Q8C8R3","Q8C8R3","Overlapped"
"OXR1_HUMAN","Q8N573","Oxidation resistance protein 1",2.7,43,2,0.3,97.97,874,5.233,"OXR1","OXR1 Nbla00307"," ","X","X"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ","X"," "," ","regulation of peptidyl-cysteine S-nitrosylation [GO:2000169]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; regulation of oxidative stress-induced neuron death [GO:1903203]; negative regulation of oxidative stress-induced cell death [GO:1903202]; regulation of oxidative stress-induced cell death [GO:1903201]; negative regulation of response to oxidative stress [GO:1902883]; regulation of response to oxidative stress [GO:1902882]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; cellular response to oxygen-containing compound [GO:1901701]; response to oxygen-containing compound [GO:1901700]; organonitrogen compound metabolic process [GO:1901564]; negative regulation of neuron death [GO:1901215]; regulation of neuron death [GO:1901214]; negative regulation of cellular response to oxidative stress [GO:1900408]; regulation of cellular response to oxidative stress [GO:1900407]; walking behavior [GO:0090659]; regulation of cellular response to stress [GO:0080135]; regulation of response to stress [GO:0080134]; regulation of primary metabolic process [GO:0080090]; organic substance metabolic process [GO:0071704]; cellular response to hydroperoxide [GO:0071447]; neuron death [GO:0070997]; cellular response to chemical stimulus [GO:0070887]; biological regulation [GO:0065007]; negative regulation of cell death [GO:0060548]; regulation of macromolecule metabolic process [GO:0060255]; cellular response to stimulus [GO:0051716]; neuron apoptotic process [GO:0051402]; negative regulation of protein metabolic process [GO:0051248]; regulation of protein metabolic process [GO:0051246]; negative regulation of nitrogen compound metabolic process [GO:0051172]; regulation of nitrogen compound metabolic process [GO:0051171]; response to stimulus [GO:0050896]; regulation of cellular process [GO:0050794]; regulation of biological process [GO:0050789]; negative regulation of response to stimulus [GO:0048585]; regulation of response to stimulus [GO:0048583]; negative regulation of cellular process [GO:0048523]; negative regulation of biological process [GO:0048519]; cellular protein metabolic process [GO:0044267]; cellular macromolecule metabolic process [GO:0044260]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; macromolecule modification [GO:0043412]; macromolecule metabolic process [GO:0043170]; negative regulation of programmed cell death [GO:0043069]; regulation of programmed cell death [GO:0043067]; negative regulation of apoptotic process [GO:0043066]; regulation of apoptotic process [GO:0042981]; response to chemical [GO:0042221]; neuron death in response to oxidative stress [GO:0036475]; cell death in response to oxidative stress [GO:0036473]; protein modification process [GO:0036211]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; response to hydroperoxide [GO:0033194]; multicellular organismal process [GO:0032501]; negative regulation of cellular protein metabolic process [GO:0032269]; regulation of cellular protein metabolic process [GO:0032268]; negative regulation of protein modification process [GO:0031400]; regulation of protein modification process [GO:0031399]; negative regulation of cellular metabolic process [GO:0031324]; regulation of cellular metabolic process [GO:0031323]; adult behavior [GO:0030534]; protein metabolic process [GO:0019538]; regulation of metabolic process [GO:0019222]; peptidyl-cysteine modification [GO:0018198]; peptidyl-amino acid modification [GO:0018193]; peptidyl-cysteine S-nitrosylation [GO:0018119]; protein nitrosylation [GO:0017014]; programmed cell death [GO:0012501]; regulation of cell death [GO:0010941]; negative regulation of macromolecule metabolic process [GO:0010605]; cellular process [GO:0009987]; negative regulation of metabolic process [GO:0009892]; adult locomotory behavior [GO:0008344]; cell death [GO:0008219]; metabolic process [GO:0008152]; biological_process [GO:0008150]; adult walking behavior [GO:0007628]; locomotory behavior [GO:0007626]; behavior [GO:0007610]; response to oxidative stress [GO:0006979]; response to stress [GO:0006950]; apoptotic process [GO:0006915]; nitrogen compound metabolic process [GO:0006807]; cellular protein modification process [GO:0006464]","oxidoreductase activity [GO:0016491]; catalytic activity [GO:0003824]; molecular_function [GO:0003674]","intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete nuclear part [GO:0044428]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular non-membrane-bounded organelle [GO:0043232]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; non-membrane-bounded organelle [GO:0043228]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; nuclear lumen [GO:0031981]; membrane-enclosed lumen [GO:0031974]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]"," ",NA," ",NA,NA,NA,"Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay (CHEGDD) [MIM:213000]: An autosomal recessive neurodevelopmental disorder characterized by infantile onset of hypotonia, global developmental delay, delayed walking, and severely impaired intellectual development with profound speech delay. Patients manifest cerebellar atrophy and childhood-onset epilepsy. {ECO:0000269|PubMed:31785787}. The disease is caused by mutations affecting the gene represented in this entry.","LysM domain [IPR018392]; LysM domain superfamily [IPR036779]; TLDc domain [IPR006571]","9606.ENSP00000405424","O43612; O43613; O43614; O95747; Q9Y4E6; P0C0P6; Q8NG92; Q8TDJ6; Q14CW9; Q86TG1; Q99689; Q9Y485; P04179; P36969; Q8NGX9; O15514; O75312; Q9Y3C7; Q96G25; Q96L92; P26641; Q99720; Q5TGY1; Q7Z419; P38606; Q15006; Q9UIJ7; P05198; P51649; Q6P499; Q13347; Q16514; Q96DP5; Q7Z7C8; O95396; Q8N0Z2; Q9Y4L1; P04040; P36543; Q12908","749; 740; 584; 562; 545; 535; 508; 503; 501; 498; 494; 488; 486; 478; 472; 464; 460; 456; 454; 452; 452; 451; 443; 443; 437; 419; 410; 410; 405; 404; 399; 397; 397; 395; 394; 388; 385; 384; 378; 377","regulation of peptidyl-cysteine S-nitrosylation [GO:2000169]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; regulation of oxidative stress-induced neuron death [GO:1903203]; negative regulation of oxidative stress-induced cell death [GO:1903202]; regulation of oxidative stress-induced cell death [GO:1903201]; negative regulation of response to oxidative stress [GO:1902883]; regulation of response to oxidative stress [GO:1902882]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; cellular response to oxygen-containing compound [GO:1901701]; response to oxygen-containing compound [GO:1901700]; organonitrogen compound metabolic process [GO:1901564]; negative regulation of neuron death [GO:1901215]; regulation of neuron death [GO:1901214]; negative regulation of cellular response to oxidative stress [GO:1900408]; regulation of cellular response to oxidative stress [GO:1900407]; walking behavior [GO:0090659]; regulation of cellular response to stress [GO:0080135]; regulation of response to stress [GO:0080134]; regulation of primary metabolic process [GO:0080090]; organic substance metabolic process [GO:0071704]; cellular response to hydroperoxide [GO:0071447]; neuron death [GO:0070997]; cellular response to chemical stimulus [GO:0070887]; biological regulation [GO:0065007]; negative regulation of cell death [GO:0060548]; regulation of macromolecule metabolic process [GO:0060255]; cellular response to stimulus [GO:0051716]; neuron apoptotic process [GO:0051402]; negative regulation of protein metabolic process [GO:0051248]; regulation of protein metabolic process [GO:0051246]; negative regulation of nitrogen compound metabolic process [GO:0051172]; regulation of nitrogen compound metabolic process [GO:0051171]; response to stimulus [GO:0050896]; regulation of cellular process [GO:0050794]; regulation of biological process [GO:0050789]; negative regulation of response to stimulus [GO:0048585]; regulation of response to stimulus [GO:0048583]; negative regulation of cellular process [GO:0048523]; negative regulation of biological process [GO:0048519]; cellular protein metabolic process [GO:0044267]; cellular macromolecule metabolic process [GO:0044260]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of neuron apoptotic process [GO:0043523]; macromolecule modification [GO:0043412]; macromolecule metabolic process [GO:0043170]; negative regulation of programmed cell death [GO:0043069]; regulation of programmed cell death [GO:0043067]; negative regulation of apoptotic process [GO:0043066]; regulation of apoptotic process [GO:0042981]; response to chemical [GO:0042221]; neuron death in response to oxidative stress [GO:0036475]; cell death in response to oxidative stress [GO:0036473]; protein modification process [GO:0036211]; cellular response to oxidative stress [GO:0034599]; cellular response to stress [GO:0033554]; response to hydroperoxide [GO:0033194]; multicellular organismal process [GO:0032501]; negative regulation of cellular protein metabolic process [GO:0032269]; regulation of cellular protein metabolic process [GO:0032268]; negative regulation of protein modification process [GO:0031400]; regulation of protein modification process [GO:0031399]; negative regulation of cellular metabolic process [GO:0031324]; regulation of cellular metabolic process [GO:0031323]; adult behavior [GO:0030534]; protein metabolic process [GO:0019538]; regulation of metabolic process [GO:0019222]; peptidyl-cysteine modification [GO:0018198]; peptidyl-amino acid modification [GO:0018193]; peptidyl-cysteine S-nitrosylation [GO:0018119]; protein nitrosylation [GO:0017014]; programmed cell death [GO:0012501]; regulation of cell death [GO:0010941]; negative regulation of macromolecule metabolic process [GO:0010605]; cellular process [GO:0009987]; negative regulation of metabolic process [GO:0009892]; adult locomotory behavior [GO:0008344]; cell death [GO:0008219]; metabolic process [GO:0008152]; biological_process [GO:0008150]; adult walking behavior [GO:0007628]; locomotory behavior [GO:0007626]; behavior [GO:0007610]; response to oxidative stress [GO:0006979]; response to stress [GO:0006950]; apoptotic process [GO:0006915]; nitrogen compound metabolic process [GO:0006807]; cellular protein modification process [GO:0006464]","oxidoreductase activity [GO:0016491]; catalytic activity [GO:0003824]; molecular_function [GO:0003674]","intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete nuclear part [GO:0044428]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular non-membrane-bounded organelle [GO:0043232]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; non-membrane-bounded organelle [GO:0043228]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; nuclear lumen [GO:0031981]; membrane-enclosed lumen [GO:0031974]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]",2,1,"Q4KMM3; I3ISS4","Q4KMM3","Overlapped"
"IL1AP_HUMAN","Q9NPH3","Interleukin-1 receptor accessory protein",1.2,43,1,0,65.418,570,7.945,"IL1RAP","IL1RAP C3orf13 IL1R3"," ","X",""," ","","","",""," ","","","","","","","",""," "," "," "," "," "," "," "," "," "," "," "," ",""," "," ",""," ","","","","","","","","X","","","","regulation of RNA biosynthetic process [GO:2001141]; positive regulation of interleukin-6 secretion [GO:2000778]; regulation of cellular macromolecule biosynthetic process [GO:2000112]; regulation of multicellular organismal development [GO:2000026]; regulation of postsynaptic density organization [GO:1905874]; regulation of presynapse assembly [GO:1905606]; positive regulation of establishment of protein localization [GO:1904951]; regulation of excitatory synapse assembly [GO:1904889]; excitatory synapse assembly [GO:1904861]; positive regulation of secretion by cell [GO:1903532]; regulation of secretion by cell [GO:1903530]; regulation of nucleic acid-templated transcription [GO:1903506]; regulation of organelle assembly [GO:1902115]; organic substance biosynthetic process [GO:1901576]; organonitrogen compound biosynthetic process [GO:1901566]; organonitrogen compound metabolic process [GO:1901564]; organic cyclic compound biosynthetic process [GO:1901362]; organic cyclic compound metabolic process [GO:1901360]; regulation of postsynapse assembly [GO:0150052]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; trans-synaptic signaling [GO:0099537]; synaptic signaling [GO:0099536]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse organization [GO:0099174]; postsynapse organization [GO:0099173]; presynapse organization [GO:0099172]; regulation of postsynaptic density assembly [GO:0099151]; regulation of postsynaptic specialization assembly [GO:0099150]; postsynaptic specialization organization [GO:0099084]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; postsynaptic specialization assembly [GO:0098698]; cell-cell adhesion [GO:0098609]; nucleic acid-templated transcription [GO:0097659]; postsynaptic density assembly [GO:0097107]; postsynaptic density organization [GO:0097106]; nucleic acid metabolic process [GO:0090304]; regulation of peptide transport [GO:0090087]; regulation of primary metabolic process [GO:0080090]; interleukin-6 secretion [GO:0072604]; interleukin-4 secretion [GO:0072602]; cellular component organization or biogenesis [GO:0071840]; nitrogen compound transport [GO:0071705]; organic substance metabolic process [GO:0071704]; organic substance transport [GO:0071702]; cellular response to interleukin-1 [GO:0071347]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic substance [GO:0071310]; organelle assembly [GO:0070925]; cellular response to chemical stimulus [GO:0070887]; response to interleukin-1 [GO:0070555]; interleukin-1-mediated signaling pathway [GO:0070498]; regulation of establishment of protein localization [GO:0070201]; regulation of molecular function [GO:0065009]; regulation of biological quality [GO:0065008]; biological regulation [GO:0065007]; protein-containing complex assembly [GO:0065003]; regulation of macromolecule metabolic process [GO:0060255]; positive regulation of synapse assembly [GO:0051965]; regulation of synapse assembly [GO:0051963]; positive regulation of nervous system development [GO:0051962]; regulation of nervous system development [GO:0051960]; cellular response to stimulus [GO:0051716]; regulation of RNA metabolic process [GO:0051252]; positive regulation of multicellular organismal process [GO:0051240]; regulation of multicellular organismal process [GO:0051239]; establishment of localization [GO:0051234]; regulation of protein transport [GO:0051223]; positive regulation of protein transport [GO:0051222]; localization [GO:0051179]; regulation of nitrogen compound metabolic process [GO:0051171]; positive regulation of cellular component organization [GO:0051130]; regulation of cellular component organization [GO:0051128]; positive regulation of developmental process [GO:0051094]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of DNA-binding transcription factor activity [GO:0051090]; positive regulation of transport [GO:0051050]; regulation of transport [GO:0051049]; positive regulation of secretion [GO:0051047]; regulation of secretion [GO:0051046]; response to stimulus [GO:0050896]; synapse organization [GO:0050808]; regulation of synapse organization [GO:0050807]; regulation of synapse structure or activity [GO:0050803]; regulation of cellular process [GO:0050794]; regulation of developmental process [GO:0050793]; regulation of biological process [GO:0050789]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of protein secretion [GO:0050714]; regulation of protein secretion [GO:0050708]; regulation of cytokine secretion [GO:0050707]; cytokine secretion [GO:0050663]; anatomical structure development [GO:0048856]; system development [GO:0048731]; positive regulation of cellular process [GO:0048522]; positive regulation of biological process [GO:0048518]; secretion [GO:0046903]; heterocycle metabolic process [GO:0046483]; establishment of protein localization [GO:0045184]; innate immune response [GO:0045087]; cellular nitrogen compound biosynthetic process [GO:0044271]; cellular macromolecule metabolic process [GO:0044260]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; positive regulation of molecular function [GO:0044093]; positive regulation of cellular component biogenesis [GO:0044089]; regulation of cellular component biogenesis [GO:0044087]; cellular component biogenesis [GO:0044085]; protein-containing complex subunit organization [GO:0043933]; macromolecule metabolic process [GO:0043170]; amide transport [GO:0042886]; response to chemical [GO:0042221]; cytokine metabolic process [GO:0042107]; interleukin-2 biosynthetic process [GO:0042094]; cytokine biosynthetic process [GO:0042089]; interleukin-33-mediated signaling pathway [GO:0038172]; nucleobase-containing compound biosynthetic process [GO:0034654]; cellular macromolecule biosynthetic process [GO:0034645]; cellular nitrogen compound metabolic process [GO:0034641]; response to cytokine [GO:0034097]; regulation of organelle organization [GO:0033043]; macromolecule localization [GO:0033036]; secretion by cell [GO:0032940]; regulation of protein localization [GO:0032880]; regulation of localization [GO:0032879]; RNA biosynthetic process [GO:0032774]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-13 production [GO:0032736]; regulation of interleukin-6 production [GO:0032675]; regulation of interleukin-5 production [GO:0032674]; regulation of interleukin-13 production [GO:0032656]; interleukin-6 production [GO:0032635]; interleukin-5 production [GO:0032634]; interleukin-4 production [GO:0032633]; interleukin-2 production [GO:0032623]; interleukin-13 production [GO:0032616]; developmental process [GO:0032502]; multicellular organismal process [GO:0032501]; regulation of cellular biosynthetic process [GO:0031326]; regulation of cellular metabolic process [GO:0031323]; signaling [GO:0023052]; biological adhesion [GO:0022610]; cellular component assembly [GO:0022607]; protein metabolic process [GO:0019538]; aromatic compound biosynthetic process [GO:0019438]; regulation of metabolic process [GO:0019222]; cytokine-mediated signaling pathway [GO:0019221]; regulation of nucleobase-containing compound metabolic process [GO:0019219]; heterocycle biosynthetic process [GO:0018130]; RNA metabolic process [GO:0016070]; cellular component organization [GO:0016043]; peptide transport [GO:0015833]; protein transport [GO:0015031]; regulation of macromolecule biosynthetic process [GO:0010556]; regulation of gene expression [GO:0010468]; gene expression [GO:0010467]; response to organic substance [GO:0010033]; cellular process [GO:0009987]; regulation of biosynthetic process [GO:0009889]; protein secretion [GO:0009306]; macromolecule biosynthetic process [GO:0009059]; biosynthetic process [GO:0009058]; metabolic process [GO:0008152]; biological_process [GO:0008150]; protein localization [GO:0008104]; synapse assembly [GO:0007416]; nervous system development [GO:0007399]; multicellular organism development [GO:0007275]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; signal transduction [GO:0007165]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; organelle organization [GO:0006996]; immune response [GO:0006955]; inflammatory response [GO:0006954]; defense response [GO:0006952]; response to stress [GO:0006950]; transport [GO:0006810]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of peptide secretion [GO:0002793]; regulation of peptide secretion [GO:0002791]; peptide secretion [GO:0002790]; immune system process [GO:0002376]; positive regulation of cytokine production [GO:0001819]; regulation of cytokine production [GO:0001817]; cytokine production [GO:0001816]","growth factor receptor binding [GO:0070851]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; molecular transducer activity [GO:0060089]; NAD(P)+ nucleosidase activity [GO:0050135]; signaling receptor activity [GO:0038023]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; hydrolase activity [GO:0016787]; protein binding [GO:0005515]; binding [GO:0005488]; interleukin-1 receptor binding [GO:0005149]; cytokine receptor binding [GO:0005126]; signaling receptor binding [GO:0005102]; interleukin-1 receptor activity [GO:0004908]; cytokine receptor activity [GO:0004896]; transmembrane signaling receptor activity [GO:0004888]; NAD+ nucleosidase activity [GO:0003953]; catalytic activity [GO:0003824]; molecular_function [GO:0003674]; interleukin-33 receptor activity [GO:0002114]","glutamatergic synapse [GO:0098978]; cell periphery [GO:0071944]; synapse [GO:0045202]; obsolete cell part [GO:0044464]; obsolete plasma membrane part [GO:0044459]; obsolete membrane part [GO:0044425]; intrinsic component of plasma membrane [GO:0031226]; intrinsic component of membrane [GO:0031224]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell [GO:0005623]; extracellular region [GO:0005576]; cellular_component [GO:0005575]"," ",NA," ",NA,NA,NA,"","Immunoglobulin-like domain [IPR007110]; Immunoglobulin-like domain superfamily [IPR036179]; Immunoglobulin-like fold [IPR013783]; IL-1Ra-like, immunoglobulin domain [IPR041416]; Immunoglobulin subtype [IPR003599]; Interleukin-1 receptor family [IPR015621]; Interleukin-1 receptor type I/II [IPR004074]; Toll/interleukin-1 receptor homology (TIR) domain [IPR000157]; Toll/interleukin-1 receptor homology (TIR) domain superfamily [IPR035897]","0","","","regulation of RNA biosynthetic process [GO:2001141]; positive regulation of interleukin-6 secretion [GO:2000778]; regulation of cellular macromolecule biosynthetic process [GO:2000112]; regulation of multicellular organismal development [GO:2000026]; regulation of postsynaptic density organization [GO:1905874]; regulation of presynapse assembly [GO:1905606]; positive regulation of establishment of protein localization [GO:1904951]; regulation of excitatory synapse assembly [GO:1904889]; excitatory synapse assembly [GO:1904861]; positive regulation of secretion by cell [GO:1903532]; regulation of secretion by cell [GO:1903530]; regulation of nucleic acid-templated transcription [GO:1903506]; regulation of organelle assembly [GO:1902115]; organic substance biosynthetic process [GO:1901576]; organonitrogen compound biosynthetic process [GO:1901566]; organonitrogen compound metabolic process [GO:1901564]; organic cyclic compound biosynthetic process [GO:1901362]; organic cyclic compound metabolic process [GO:1901360]; regulation of postsynapse assembly [GO:0150052]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]; trans-synaptic signaling [GO:0099537]; synaptic signaling [GO:0099536]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse organization [GO:0099174]; postsynapse organization [GO:0099173]; presynapse organization [GO:0099172]; regulation of postsynaptic density assembly [GO:0099151]; regulation of postsynaptic specialization assembly [GO:0099150]; postsynaptic specialization organization [GO:0099084]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; postsynaptic specialization assembly [GO:0098698]; cell-cell adhesion [GO:0098609]; nucleic acid-templated transcription [GO:0097659]; postsynaptic density assembly [GO:0097107]; postsynaptic density organization [GO:0097106]; nucleic acid metabolic process [GO:0090304]; regulation of peptide transport [GO:0090087]; regulation of primary metabolic process [GO:0080090]; interleukin-6 secretion [GO:0072604]; interleukin-4 secretion [GO:0072602]; cellular component organization or biogenesis [GO:0071840]; nitrogen compound transport [GO:0071705]; organic substance metabolic process [GO:0071704]; organic substance transport [GO:0071702]; cellular response to interleukin-1 [GO:0071347]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic substance [GO:0071310]; organelle assembly [GO:0070925]; cellular response to chemical stimulus [GO:0070887]; response to interleukin-1 [GO:0070555]; interleukin-1-mediated signaling pathway [GO:0070498]; regulation of establishment of protein localization [GO:0070201]; regulation of molecular function [GO:0065009]; regulation of biological quality [GO:0065008]; biological regulation [GO:0065007]; protein-containing complex assembly [GO:0065003]; regulation of macromolecule metabolic process [GO:0060255]; positive regulation of synapse assembly [GO:0051965]; regulation of synapse assembly [GO:0051963]; positive regulation of nervous system development [GO:0051962]; regulation of nervous system development [GO:0051960]; cellular response to stimulus [GO:0051716]; regulation of RNA metabolic process [GO:0051252]; positive regulation of multicellular organismal process [GO:0051240]; regulation of multicellular organismal process [GO:0051239]; establishment of localization [GO:0051234]; regulation of protein transport [GO:0051223]; positive regulation of protein transport [GO:0051222]; localization [GO:0051179]; regulation of nitrogen compound metabolic process [GO:0051171]; positive regulation of cellular component organization [GO:0051130]; regulation of cellular component organization [GO:0051128]; positive regulation of developmental process [GO:0051094]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; regulation of DNA-binding transcription factor activity [GO:0051090]; positive regulation of transport [GO:0051050]; regulation of transport [GO:0051049]; positive regulation of secretion [GO:0051047]; regulation of secretion [GO:0051046]; response to stimulus [GO:0050896]; synapse organization [GO:0050808]; regulation of synapse organization [GO:0050807]; regulation of synapse structure or activity [GO:0050803]; regulation of cellular process [GO:0050794]; regulation of developmental process [GO:0050793]; regulation of biological process [GO:0050789]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of protein secretion [GO:0050714]; regulation of protein secretion [GO:0050708]; regulation of cytokine secretion [GO:0050707]; cytokine secretion [GO:0050663]; anatomical structure development [GO:0048856]; system development [GO:0048731]; positive regulation of cellular process [GO:0048522]; positive regulation of biological process [GO:0048518]; secretion [GO:0046903]; heterocycle metabolic process [GO:0046483]; establishment of protein localization [GO:0045184]; innate immune response [GO:0045087]; cellular nitrogen compound biosynthetic process [GO:0044271]; cellular macromolecule metabolic process [GO:0044260]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; positive regulation of molecular function [GO:0044093]; positive regulation of cellular component biogenesis [GO:0044089]; regulation of cellular component biogenesis [GO:0044087]; cellular component biogenesis [GO:0044085]; protein-containing complex subunit organization [GO:0043933]; macromolecule metabolic process [GO:0043170]; amide transport [GO:0042886]; response to chemical [GO:0042221]; cytokine metabolic process [GO:0042107]; interleukin-2 biosynthetic process [GO:0042094]; cytokine biosynthetic process [GO:0042089]; interleukin-33-mediated signaling pathway [GO:0038172]; nucleobase-containing compound biosynthetic process [GO:0034654]; cellular macromolecule biosynthetic process [GO:0034645]; cellular nitrogen compound metabolic process [GO:0034641]; response to cytokine [GO:0034097]; regulation of organelle organization [GO:0033043]; macromolecule localization [GO:0033036]; secretion by cell [GO:0032940]; regulation of protein localization [GO:0032880]; regulation of localization [GO:0032879]; RNA biosynthetic process [GO:0032774]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-13 production [GO:0032736]; regulation of interleukin-6 production [GO:0032675]; regulation of interleukin-5 production [GO:0032674]; regulation of interleukin-13 production [GO:0032656]; interleukin-6 production [GO:0032635]; interleukin-5 production [GO:0032634]; interleukin-4 production [GO:0032633]; interleukin-2 production [GO:0032623]; interleukin-13 production [GO:0032616]; developmental process [GO:0032502]; multicellular organismal process [GO:0032501]; regulation of cellular biosynthetic process [GO:0031326]; regulation of cellular metabolic process [GO:0031323]; signaling [GO:0023052]; biological adhesion [GO:0022610]; cellular component assembly [GO:0022607]; protein metabolic process [GO:0019538]; aromatic compound biosynthetic process [GO:0019438]; regulation of metabolic process [GO:0019222]; cytokine-mediated signaling pathway [GO:0019221]; regulation of nucleobase-containing compound metabolic process [GO:0019219]; heterocycle biosynthetic process [GO:0018130]; RNA metabolic process [GO:0016070]; cellular component organization [GO:0016043]; peptide transport [GO:0015833]; protein transport [GO:0015031]; regulation of macromolecule biosynthetic process [GO:0010556]; regulation of gene expression [GO:0010468]; gene expression [GO:0010467]; response to organic substance [GO:0010033]; cellular process [GO:0009987]; regulation of biosynthetic process [GO:0009889]; protein secretion [GO:0009306]; macromolecule biosynthetic process [GO:0009059]; biosynthetic process [GO:0009058]; metabolic process [GO:0008152]; biological_process [GO:0008150]; protein localization [GO:0008104]; synapse assembly [GO:0007416]; nervous system development [GO:0007399]; multicellular organism development [GO:0007275]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; signal transduction [GO:0007165]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; organelle organization [GO:0006996]; immune response [GO:0006955]; inflammatory response [GO:0006954]; defense response [GO:0006952]; response to stress [GO:0006950]; transport [GO:0006810]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of peptide secretion [GO:0002793]; regulation of peptide secretion [GO:0002791]; peptide secretion [GO:0002790]; immune system process [GO:0002376]; positive regulation of cytokine production [GO:0001819]; regulation of cytokine production [GO:0001817]; cytokine production [GO:0001816]","growth factor receptor binding [GO:0070851]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]; molecular transducer activity [GO:0060089]; NAD(P)+ nucleosidase activity [GO:0050135]; signaling receptor activity [GO:0038023]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; hydrolase activity [GO:0016787]; protein binding [GO:0005515]; binding [GO:0005488]; interleukin-1 receptor binding [GO:0005149]; cytokine receptor binding [GO:0005126]; signaling receptor binding [GO:0005102]; interleukin-1 receptor activity [GO:0004908]; cytokine receptor activity [GO:0004896]; transmembrane signaling receptor activity [GO:0004888]; NAD+ nucleosidase activity [GO:0003953]; catalytic activity [GO:0003824]; molecular_function [GO:0003674]; interleukin-33 receptor activity [GO:0002114]","glutamatergic synapse [GO:0098978]; cell periphery [GO:0071944]; synapse [GO:0045202]; obsolete cell part [GO:0044464]; obsolete plasma membrane part [GO:0044459]; obsolete membrane part [GO:0044425]; intrinsic component of plasma membrane [GO:0031226]; intrinsic component of membrane [GO:0031224]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell [GO:0005623]; extracellular region [GO:0005576]; cellular_component [GO:0005575]",0,0,"","","Overlapped"
"THOC2_HUMAN","Q8NI27","THO complex subunit 2",29.4,43,13,12.3,182.775,1593,8.335,"THOC2","THOC2 CXorf3"," "," ","X"," "," "," "," ","X"," "," ","X"," "," "," "," ","X"," "," "," "," "," "," "," "," "," "," "," "," ","X","X"," "," "," ","X","X"," ","X","X"," ","X"," ","X","X"," "," ","regulation of ribonucleoprotein complex localization [GO:2000197]; regulation of multicellular organismal development [GO:2000026]; regulation of cellular protein localization [GO:1903827]; multi-organism localization [GO:1902579]; organic cyclic compound metabolic process [GO:1901360]; plasma membrane bounded cell projection organization [GO:0120036]; regulation of plasma membrane bounded cell projection organization [GO:0120035]; nucleic acid metabolic process [GO:0090304]; regulation of peptide transport [GO:0090087]; cellular component organization or biogenesis [GO:0071840]; nitrogen compound transport [GO:0071705]; organic substance metabolic process [GO:0071704]; organic substance transport [GO:0071702]; mRNA-containing ribonucleoprotein complex export from nucleus [GO:0071427]; ribonucleoprotein complex export from nucleus [GO:0071426]; ribonucleoprotein complex localization [GO:0071166]; cellular macromolecule localization [GO:0070727]; regulation of establishment of protein localization [GO:0070201]; biological regulation [GO:0065007]; regulation of cellular localization [GO:0060341]; regulation of cell development [GO:0060284]; regulation of macromolecule metabolic process [GO:0060255]; negative regulation of nervous system development [GO:0051961]; regulation of nervous system development [GO:0051960]; multi-organism process [GO:0051704]; interaction with host [GO:0051701]; establishment of localization in cell [GO:0051649]; cellular localization [GO:0051641]; cell division [GO:0051301]; negative regulation of multicellular organismal process [GO:0051241]; regulation of multicellular organismal process [GO:0051239]; establishment of RNA localization [GO:0051236]; establishment of localization [GO:0051234]; regulation of protein transport [GO:0051223]; localization [GO:0051179]; nuclear transport [GO:0051169]; nuclear export [GO:0051168]; negative regulation of cellular component organization [GO:0051129]; regulation of cellular component organization [GO:0051128]; negative regulation of developmental process [GO:0051093]; regulation of transport [GO:0051049]; mRNA transport [GO:0051028]; regulation of cellular process [GO:0050794]; regulation of developmental process [GO:0050793]; regulation of biological process [GO:0050789]; negative regulation of neurogenesis [GO:0050768]; regulation of neurogenesis [GO:0050767]; RNA transport [GO:0050658]; nucleic acid transport [GO:0050657]; cellular developmental process [GO:0048869]; anatomical structure development [GO:0048856]; system development [GO:0048731]; generation of neurons [GO:0048699]; neuron development [GO:0048666]; negative regulation of cellular process [GO:0048523]; negative regulation of biological process [GO:0048519]; cell development [GO:0048468]; intracellular transport [GO:0046907]; regulation of RNA export from nucleus [GO:0046831]; regulation of protein export from nucleus [GO:0046825]; regulation of nucleocytoplasmic transport [GO:0046822]; viral mRNA export from host cell nucleus [GO:0046784]; heterocycle metabolic process [GO:0046483]; negative regulation of neuron differentiation [GO:0045665]; regulation of neuron differentiation [GO:0045664]; negative regulation of cell differentiation [GO:0045596]; regulation of cell differentiation [GO:0045595]; establishment of protein localization [GO:0045184]; multi-organism transport [GO:0044766]; interspecies interaction between organisms [GO:0044419]; translocation of molecules into host [GO:0044417]; symbiotic process [GO:0044403]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; macromolecule metabolic process [GO:0043170]; chordate embryonic development [GO:0043009]; amide transport [GO:0042886]; cellular nitrogen compound metabolic process [GO:0034641]; cellular protein localization [GO:0034613]; regulation of intracellular protein transport [GO:0033157]; macromolecule localization [GO:0033036]; cellular component morphogenesis [GO:0032989]; regulation of protein localization [GO:0032880]; regulation of localization [GO:0032879]; developmental process [GO:0032502]; multicellular organismal process [GO:0032501]; regulation of intracellular transport [GO:0032386]; regulation of nucleobase-containing compound transport [GO:0032239]; protein-containing complex localization [GO:0031503]; negative regulation of cell projection organization [GO:0031345]; regulation of cell projection organization [GO:0031344]; neuron projection development [GO:0031175]; mRNA 3'-end processing [GO:0031124]; RNA 3'-end processing [GO:0031123]; neuron differentiation [GO:0030182]; cell differentiation [GO:0030154]; cell projection organization [GO:0030030]; neurogenesis [GO:0022008]; regulation of metabolic process [GO:0019222]; stem cell division [GO:0017145]; poly(A)+ mRNA export from nucleus [GO:0016973]; mRNA metabolic process [GO:0016071]; RNA metabolic process [GO:0016070]; cellular component organization [GO:0016043]; nucleobase-containing compound transport [GO:0015931]; peptide transport [GO:0015833]; protein transport [GO:0015031]; negative regulation of neuron projection development [GO:0010977]; regulation of neuron projection development [GO:0010975]; regulation of mRNA export from nucleus [GO:0010793]; negative regulation of cell development [GO:0010721]; regulation of gene expression [GO:0010468]; gene expression [GO:0010467]; cellular process [GO:0009987]; embryo development ending in birth or egg hatching [GO:0009792]; embryo development [GO:0009790]; anatomical structure morphogenesis [GO:0009653]; RNA splicing [GO:0008380]; metabolic process [GO:0008152]; biological_process [GO:0008150]; protein localization [GO:0008104]; nervous system development [GO:0007399]; multicellular organism development [GO:0007275]; nucleocytoplasmic transport [GO:0006913]; intracellular protein transport [GO:0006886]; transport [GO:0006810]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; protein export from nucleus [GO:0006611]; mRNA export from nucleus [GO:0006406]; RNA export from nucleus [GO:0006405]; RNA localization [GO:0006403]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]; nucleobase-containing compound metabolic process [GO:0006139]; blastocyst development [GO:0001824]; in utero embryonic development [GO:0001701]; cell morphogenesis [GO:0000902]","heterocyclic compound binding [GO:1901363]; organic cyclic compound binding [GO:0097159]; binding [GO:0005488]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; nucleic acid binding [GO:0003676]; molecular_function [GO:0003674]","intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete nucleoplasm part [GO:0044451]; obsolete intracellular organelle part [GO:0044446]; obsolete nuclear part [GO:0044428]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; protein-containing complex [GO:0032991]; nuclear lumen [GO:0031981]; membrane-enclosed lumen [GO:0031974]; nuclear speck [GO:0016607]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]; THO complex part of transcription export complex [GO:0000445]; THO complex [GO:0000347]; transcription export complex [GO:0000346]"," ",NA," ",NA,NA,NA,"Mental retardation, X-linked 12 (MRX12) [MIM:300957]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. MRX12 patients manifest variable degrees of intellectual disability. Commonly observed features included speech delay, elevated BMI, short stature, seizure disorders, gait disturbance, and tremors. {ECO:0000269|PubMed:26166480}. The disease is caused by mutations affecting the gene represented in this entry.","THO complex subunit 2 [IPR040007]; THO complex, subunitTHOC2, C-terminal [IPR021418]; THO complex, subunitTHOC2, N-terminal [IPR021726]; THO complex subunit 2, N-terminal domain [IPR032302]","9606.ENSP00000245838","Q86V81; Q13769; Q13838; Q09161; Q86W42; Q6I9Y2; Q96J01; Q96FV9; O00148; Q9UBU9; Q9Y3Y2; P82979; O94913; Q9BY77; P52298; P38919; Q07955; Q96QD9; P35658; Q9BZI7; P12270; P78406; O75152; P26368; P84103; Q86U42; Q9UKK6; Q8WUM0; P61326; Q16629; Q96A72; P49790; Q12996; P33240; Q99567; Q9UKF6; O60318; Q13247; Q10570; Q13242","999; 999; 999; 999; 999; 999; 999; 999; 991; 987; 983; 982; 980; 976; 976; 975; 969; 969; 968; 967; 965; 964; 963; 954; 953; 952; 951; 949; 944; 944; 942; 938; 938; 937; 936; 936; 935; 935; 934; 933","regulation of ribonucleoprotein complex localization [GO:2000197]; regulation of multicellular organismal development [GO:2000026]; regulation of cellular protein localization [GO:1903827]; multi-organism localization [GO:1902579]; organic cyclic compound metabolic process [GO:1901360]; plasma membrane bounded cell projection organization [GO:0120036]; regulation of plasma membrane bounded cell projection organization [GO:0120035]; nucleic acid metabolic process [GO:0090304]; regulation of peptide transport [GO:0090087]; cellular component organization or biogenesis [GO:0071840]; nitrogen compound transport [GO:0071705]; organic substance metabolic process [GO:0071704]; organic substance transport [GO:0071702]; mRNA-containing ribonucleoprotein complex export from nucleus [GO:0071427]; ribonucleoprotein complex export from nucleus [GO:0071426]; ribonucleoprotein complex localization [GO:0071166]; cellular macromolecule localization [GO:0070727]; regulation of establishment of protein localization [GO:0070201]; biological regulation [GO:0065007]; regulation of cellular localization [GO:0060341]; regulation of cell development [GO:0060284]; regulation of macromolecule metabolic process [GO:0060255]; negative regulation of nervous system development [GO:0051961]; regulation of nervous system development [GO:0051960]; multi-organism process [GO:0051704]; interaction with host [GO:0051701]; establishment of localization in cell [GO:0051649]; cellular localization [GO:0051641]; cell division [GO:0051301]; negative regulation of multicellular organismal process [GO:0051241]; regulation of multicellular organismal process [GO:0051239]; establishment of RNA localization [GO:0051236]; establishment of localization [GO:0051234]; regulation of protein transport [GO:0051223]; localization [GO:0051179]; nuclear transport [GO:0051169]; nuclear export [GO:0051168]; negative regulation of cellular component organization [GO:0051129]; regulation of cellular component organization [GO:0051128]; negative regulation of developmental process [GO:0051093]; regulation of transport [GO:0051049]; mRNA transport [GO:0051028]; regulation of cellular process [GO:0050794]; regulation of developmental process [GO:0050793]; regulation of biological process [GO:0050789]; negative regulation of neurogenesis [GO:0050768]; regulation of neurogenesis [GO:0050767]; RNA transport [GO:0050658]; nucleic acid transport [GO:0050657]; cellular developmental process [GO:0048869]; anatomical structure development [GO:0048856]; system development [GO:0048731]; generation of neurons [GO:0048699]; neuron development [GO:0048666]; negative regulation of cellular process [GO:0048523]; negative regulation of biological process [GO:0048519]; cell development [GO:0048468]; intracellular transport [GO:0046907]; regulation of RNA export from nucleus [GO:0046831]; regulation of protein export from nucleus [GO:0046825]; regulation of nucleocytoplasmic transport [GO:0046822]; viral mRNA export from host cell nucleus [GO:0046784]; heterocycle metabolic process [GO:0046483]; negative regulation of neuron differentiation [GO:0045665]; regulation of neuron differentiation [GO:0045664]; negative regulation of cell differentiation [GO:0045596]; regulation of cell differentiation [GO:0045595]; establishment of protein localization [GO:0045184]; multi-organism transport [GO:0044766]; interspecies interaction between organisms [GO:0044419]; translocation of molecules into host [GO:0044417]; symbiotic process [GO:0044403]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; macromolecule metabolic process [GO:0043170]; chordate embryonic development [GO:0043009]; amide transport [GO:0042886]; cellular nitrogen compound metabolic process [GO:0034641]; cellular protein localization [GO:0034613]; regulation of intracellular protein transport [GO:0033157]; macromolecule localization [GO:0033036]; cellular component morphogenesis [GO:0032989]; regulation of protein localization [GO:0032880]; regulation of localization [GO:0032879]; developmental process [GO:0032502]; multicellular organismal process [GO:0032501]; regulation of intracellular transport [GO:0032386]; regulation of nucleobase-containing compound transport [GO:0032239]; protein-containing complex localization [GO:0031503]; negative regulation of cell projection organization [GO:0031345]; regulation of cell projection organization [GO:0031344]; neuron projection development [GO:0031175]; mRNA 3'-end processing [GO:0031124]; RNA 3'-end processing [GO:0031123]; neuron differentiation [GO:0030182]; cell differentiation [GO:0030154]; cell projection organization [GO:0030030]; neurogenesis [GO:0022008]; regulation of metabolic process [GO:0019222]; stem cell division [GO:0017145]; poly(A)+ mRNA export from nucleus [GO:0016973]; mRNA metabolic process [GO:0016071]; RNA metabolic process [GO:0016070]; cellular component organization [GO:0016043]; nucleobase-containing compound transport [GO:0015931]; peptide transport [GO:0015833]; protein transport [GO:0015031]; negative regulation of neuron projection development [GO:0010977]; regulation of neuron projection development [GO:0010975]; regulation of mRNA export from nucleus [GO:0010793]; negative regulation of cell development [GO:0010721]; regulation of gene expression [GO:0010468]; gene expression [GO:0010467]; cellular process [GO:0009987]; embryo development ending in birth or egg hatching [GO:0009792]; embryo development [GO:0009790]; anatomical structure morphogenesis [GO:0009653]; RNA splicing [GO:0008380]; metabolic process [GO:0008152]; biological_process [GO:0008150]; protein localization [GO:0008104]; nervous system development [GO:0007399]; multicellular organism development [GO:0007275]; nucleocytoplasmic transport [GO:0006913]; intracellular protein transport [GO:0006886]; transport [GO:0006810]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; protein export from nucleus [GO:0006611]; mRNA export from nucleus [GO:0006406]; RNA export from nucleus [GO:0006405]; RNA localization [GO:0006403]; mRNA processing [GO:0006397]; RNA processing [GO:0006396]; nucleobase-containing compound metabolic process [GO:0006139]; blastocyst development [GO:0001824]; in utero embryonic development [GO:0001701]; cell morphogenesis [GO:0000902]","heterocyclic compound binding [GO:1901363]; organic cyclic compound binding [GO:0097159]; binding [GO:0005488]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; nucleic acid binding [GO:0003676]; molecular_function [GO:0003674]","intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete nucleoplasm part [GO:0044451]; obsolete intracellular organelle part [GO:0044446]; obsolete nuclear part [GO:0044428]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; protein-containing complex [GO:0032991]; nuclear lumen [GO:0031981]; membrane-enclosed lumen [GO:0031974]; nuclear speck [GO:0016607]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]; THO complex part of transcription export complex [GO:0000445]; THO complex [GO:0000347]; transcription export complex [GO:0000346]",2,2,"B1AZI6; E9Q5E2","B1AZI6; E9Q5E2","Upstream"
"AK1BF_HUMAN","C9JRZ8","Aldo-keto reductase family 1 member B15",7.9,43,1,5.8,36.537,316,6.387,"AKR1B15","AKR1B15"," "," "," "," "," "," "," "," "," "," ","X"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ","organic substance biosynthetic process [GO:1901576]; organic cyclic compound biosynthetic process [GO:1901362]; organic cyclic compound metabolic process [GO:1901360]; organic substance metabolic process [GO:0071704]; regulation of biological quality [GO:0065008]; biological regulation [GO:0065007]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; hormone biosynthetic process [GO:0042446]; hormone metabolic process [GO:0042445]; cellular hormone metabolic process [GO:0034754]; regulation of hormone levels [GO:0010817]; cellular process [GO:0009987]; biosynthetic process [GO:0009058]; lipid biosynthetic process [GO:0008610]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; metabolic process [GO:0008152]; biological_process [GO:0008150]; estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]; lipid metabolic process [GO:0006629]","NADP-retinol dehydrogenase activity [GO:0052650]; farnesol dehydrogenase activity [GO:0047886]; allyl-alcohol dehydrogenase activity [GO:0047655]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0033764]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; aldo-keto reductase (NADP) activity [GO:0004033]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; catalytic activity [GO:0003824]; molecular_function [GO:0003674]","intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete mitochondrial part [GO:0044429]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; membrane-enclosed lumen [GO:0031974]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]"," ",NA," ",NA,NA,NA,"","Aldo/keto reductase, conserved site [IPR018170]; Aldo/keto reductase [IPR020471]; NADP-dependent oxidoreductase domain [IPR023210]; NADP-dependent oxidoreductase domain superfamily [IPR036812]","9606.ENSP00000389289","P09104; P22392; P31948; P49773; P06733; P15121; P29401; Q04760; O43448; Q13303; O60218; O43488; Q14722; O95154; Q00796; Q8NGX2; Q99714; Q3LXA3; O75191; P37837; P00441; Q9UQ10; Q9BT78; P48506; Q6S8J3; Q8TBY9; P22607; P30520; Q9H078; Q8NBN7; P22760; Q5JTJ3; O60812; O00764; Q01850; P04179; Q8N357; Q3KQV9; O60701; Q01804","889; 877; 835; 823; 731; 701; 650; 640; 596; 577; 528; 510; 498; 486; 478; 455; 452; 446; 424; 418; 417; 413; 404; 392; 385; 374; 367; 363; 357; 356; 356; 354; 351; 347; 347; 344; 341; 337; 336; 330","organic substance biosynthetic process [GO:1901576]; organic cyclic compound biosynthetic process [GO:1901362]; organic cyclic compound metabolic process [GO:1901360]; organic substance metabolic process [GO:0071704]; regulation of biological quality [GO:0065008]; biological regulation [GO:0065007]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; hormone biosynthetic process [GO:0042446]; hormone metabolic process [GO:0042445]; cellular hormone metabolic process [GO:0034754]; regulation of hormone levels [GO:0010817]; cellular process [GO:0009987]; biosynthetic process [GO:0009058]; lipid biosynthetic process [GO:0008610]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; metabolic process [GO:0008152]; biological_process [GO:0008150]; estrogen biosynthetic process [GO:0006703]; steroid biosynthetic process [GO:0006694]; lipid metabolic process [GO:0006629]","NADP-retinol dehydrogenase activity [GO:0052650]; farnesol dehydrogenase activity [GO:0047886]; allyl-alcohol dehydrogenase activity [GO:0047655]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0033764]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity [GO:0016491]; steroid dehydrogenase activity [GO:0016229]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; aldo-keto reductase (NADP) activity [GO:0004033]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; catalytic activity [GO:0003824]; molecular_function [GO:0003674]","intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete mitochondrial part [GO:0044429]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; membrane-enclosed lumen [GO:0031974]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]",4,0,"O60218; P45376; P21300; Q5TYY5","","Upstream"
"SDC1_HUMAN","P18827","Syndecan-1",3.3,43,2,0.8,32.462,310,4.394,"SDC1","SDC1 SDC"," "," ","X"," "," "," "," "," "," "," "," "," "," "," "," ","X"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ","exosomal secretion [GO:1990182]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; positive regulation of extracellular exosome assembly [GO:1903553]; regulation of extracellular exosome assembly [GO:1903551]; positive regulation of exosomal secretion [GO:1903543]; regulation of exosomal secretion [GO:1903541]; positive regulation of secretion by cell [GO:1903532]; regulation of secretion by cell [GO:1903530]; positive regulation of organelle assembly [GO:1902117]; regulation of organelle assembly [GO:1902115]; response to oxygen-containing compound [GO:1901700]; response to nitrogen compound [GO:1901698]; organic substance biosynthetic process [GO:1901576]; organic substance catabolic process [GO:1901575]; organonitrogen compound biosynthetic process [GO:1901566]; organonitrogen compound catabolic process [GO:1901565]; organonitrogen compound metabolic process [GO:1901564]; carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate derivative catabolic process [GO:1901136]; carbohydrate derivative metabolic process [GO:1901135]; cell-cell signaling by wnt [GO:0198738]; extracellular vesicle biogenesis [GO:0140112]; extracellular exosome biogenesis [GO:0097734]; mesonephric tubule development [GO:0072164]; mesonephric epithelium development [GO:0072163]; kidney epithelium development [GO:0072073]; renal system development [GO:0072001]; extracellular exosome assembly [GO:0071971]; cellular component organization or biogenesis [GO:0071840]; organic substance metabolic process [GO:0071704]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic substance [GO:0071310]; organelle assembly [GO:0070925]; cellular response to chemical stimulus [GO:0070887]; biological regulation [GO:0065007]; reproductive system development [GO:0061458]; muscle structure development [GO:0061061]; regulation of vesicle-mediated transport [GO:0060627]; epithelium development [GO:0060429]; canonical Wnt signaling pathway [GO:0060070]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; striated muscle cell development [GO:0055002]; muscle cell development [GO:0055001]; cellular response to stimulus [GO:0051716]; localization of cell [GO:0051674]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; establishment of localization [GO:0051234]; localization [GO:0051179]; striated muscle cell differentiation [GO:0051146]; positive regulation of cellular component organization [GO:0051130]; regulation of cellular component organization [GO:0051128]; positive regulation of transport [GO:0051050]; regulation of transport [GO:0051049]; positive regulation of secretion [GO:0051047]; regulation of secretion [GO:0051046]; leukocyte migration [GO:0050900]; response to stimulus [GO:0050896]; regulation of cellular process [GO:0050794]; regulation of biological process [GO:0050789]; cell motility [GO:0048870]; cellular developmental process [GO:0048869]; anatomical structure development [GO:0048856]; system development [GO:0048731]; myoblast development [GO:0048627]; reproductive structure development [GO:0048608]; response to steroid hormone [GO:0048545]; positive regulation of cellular process [GO:0048522]; positive regulation of biological process [GO:0048518]; animal organ development [GO:0048513]; cell development [GO:0048468]; secretion [GO:0046903]; response to organophosphorus [GO:0046683]; response to antibiotic [GO:0046677]; male sex differentiation [GO:0046661]; development of primary male sexual characteristics [GO:0046546]; positive regulation of exocytosis [GO:0045921]; myoblast differentiation [GO:0045445]; development of primary sexual characteristics [GO:0045137]; cellular lipid metabolic process [GO:0044255]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; positive regulation of cellular component biogenesis [GO:0044089]; regulation of cellular component biogenesis [GO:0044087]; cellular component biogenesis [GO:0044085]; macromolecule metabolic process [GO:0043170]; extracellular structure organization [GO:0043062]; muscle cell differentiation [GO:0042692]; response to hydrogen peroxide [GO:0042542]; response to drug [GO:0042493]; odontogenesis [GO:0042476]; response to chemical [GO:0042221]; wound healing [GO:0042060]; locomotion [GO:0040011]; tube development [GO:0035295]; response to cytokine [GO:0034097]; response to lipid [GO:0033993]; regulation of organelle organization [GO:0033043]; secretion by cell [GO:0032940]; regulation of localization [GO:0032879]; developmental process [GO:0032502]; multicellular organismal process [GO:0032501]; response to corticosteroid [GO:0031960]; epithelial cell differentiation [GO:0030855]; glycosaminoglycan metabolic process [GO:0030203]; cell differentiation [GO:0030154]; signaling [GO:0023052]; cellular component assembly [GO:0022607]; reproductive process [GO:0022414]; cytokine-mediated signaling pathway [GO:0019221]; regulation of exocytosis [GO:0017157]; cell migration [GO:0016477]; vesicle-mediated transport [GO:0016192]; diterpenoid metabolic process [GO:0016101]; Wnt signaling pathway [GO:0016055]; vesicle organization [GO:0016050]; cellular component organization [GO:0016043]; response to purine-containing compound [GO:0014074]; response to organic cyclic compound [GO:0014070]; positive regulation of organelle organization [GO:0010638]; response to organonitrogen compound [GO:0010243]; response to metal ion [GO:0010038]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; cellular process [GO:0009987]; tissue development [GO:0009888]; animal organ morphogenesis [GO:0009887]; response to hormone [GO:0009725]; response to endogenous stimulus [GO:0009719]; anatomical structure morphogenesis [GO:0009653]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; macromolecule biosynthetic process [GO:0009059]; biosynthetic process [GO:0009058]; macromolecule catabolic process [GO:0009057]; catabolic process [GO:0009056]; male gonad development [GO:0008584]; gonad development [GO:0008406]; metabolic process [GO:0008152]; biological_process [GO:0008150]; sex differentiation [GO:0007548]; multicellular organism development [GO:0007275]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; signal transduction [GO:0007165]; cell communication [GO:0007154]; organelle organization [GO:0006996]; response to oxidative stress [GO:0006979]; inflammatory response [GO:0006954]; defense response [GO:0006952]; response to stress [GO:0006950]; movement of cell or subcellular component [GO:0006928]; exocytosis [GO:0006887]; transport [GO:0006810]; nitrogen compound metabolic process [GO:0006807]; terpenoid metabolic process [GO:0006721]; isoprenoid metabolic process [GO:0006720]; lipid metabolic process [GO:0006629]; glycosaminoglycan catabolic process [GO:0006027]; aminoglycan catabolic process [GO:0006026]; glycosaminoglycan biosynthetic process [GO:0006024]; aminoglycan biosynthetic process [GO:0006023]; aminoglycan metabolic process [GO:0006022]; developmental process involved in reproduction [GO:0003006]; immune system process [GO:0002376]; epithelial cell development [GO:0002064]; mesonephros development [GO:0001823]; kidney development [GO:0001822]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; retinoid metabolic process [GO:0001523]; response to reactive oxygen species [GO:0000302]; reproduction [GO:0000003]","identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein binding [GO:0005515]; binding [GO:0005488]; molecular_function [GO:0003674]","extracellular vesicle [GO:1903561]; side of membrane [GO:0098552]; cell periphery [GO:0071944]; extracellular exosome [GO:0070062]; intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete plasma membrane part [GO:0044459]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete vacuolar part [GO:0044437]; obsolete Golgi apparatus part [GO:0044431]; obsolete membrane part [GO:0044425]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; obsolete extracellular region part [GO:0044421]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; extracellular organelle [GO:0043230]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; lysosomal lumen [GO:0043202]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; membrane-enclosed lumen [GO:0031974]; intrinsic component of plasma membrane [GO:0031226]; intrinsic component of membrane [GO:0031224]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endomembrane system [GO:0012505]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Golgi lumen [GO:0005796]; Golgi apparatus [GO:0005794]; vacuolar lumen [GO:0005775]; vacuole [GO:0005773]; lysosome [GO:0005764]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; extracellular space [GO:0005615]; extracellular region [GO:0005576]; cellular_component [GO:0005575]; lytic vacuole [GO:0000323]"," ",NA," ",NA,NA,NA,"","Neurexin/syndecan/glycophorin C [IPR003585]; Syndecan [IPR001050]; Syndecan-1 [IPR031190]; Syndecan/Neurexin domain [IPR027789]; Syndecan, conserved site [IPR030479]","9606.ENSP00000370542","O00560; P09038; P35052; P14210; P98160; Q9Y625; O75487; Q8N158; P78333; P51654; O00468; P07585; P21810; P13501; Q9Y251; P13611; P09237; Q16394; P14780; P34741; O14936; P52848; O75056; P22607; Q7LGA3; Q93063; P04004; P35613; P17301; P27361; P05556; Q8WWQ2; P08581; O60243; O94923; O14792; Q9P2W7; P52849; P07996; P02649","986; 981; 980; 976; 975; 969; 969; 968; 967; 965; 958; 958; 953; 952; 951; 951; 950; 948; 947; 946; 945; 945; 943; 943; 942; 939; 939; 938; 938; 938; 937; 936; 936; 936; 935; 935; 932; 930; 930; 929","exosomal secretion [GO:1990182]; cell surface receptor signaling pathway involved in cell-cell signaling [GO:1905114]; positive regulation of extracellular exosome assembly [GO:1903553]; regulation of extracellular exosome assembly [GO:1903551]; positive regulation of exosomal secretion [GO:1903543]; regulation of exosomal secretion [GO:1903541]; positive regulation of secretion by cell [GO:1903532]; regulation of secretion by cell [GO:1903530]; positive regulation of organelle assembly [GO:1902117]; regulation of organelle assembly [GO:1902115]; response to oxygen-containing compound [GO:1901700]; response to nitrogen compound [GO:1901698]; organic substance biosynthetic process [GO:1901576]; organic substance catabolic process [GO:1901575]; organonitrogen compound biosynthetic process [GO:1901566]; organonitrogen compound catabolic process [GO:1901565]; organonitrogen compound metabolic process [GO:1901564]; carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate derivative catabolic process [GO:1901136]; carbohydrate derivative metabolic process [GO:1901135]; cell-cell signaling by wnt [GO:0198738]; extracellular vesicle biogenesis [GO:0140112]; extracellular exosome biogenesis [GO:0097734]; mesonephric tubule development [GO:0072164]; mesonephric epithelium development [GO:0072163]; kidney epithelium development [GO:0072073]; renal system development [GO:0072001]; extracellular exosome assembly [GO:0071971]; cellular component organization or biogenesis [GO:0071840]; organic substance metabolic process [GO:0071704]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic substance [GO:0071310]; organelle assembly [GO:0070925]; cellular response to chemical stimulus [GO:0070887]; biological regulation [GO:0065007]; reproductive system development [GO:0061458]; muscle structure development [GO:0061061]; regulation of vesicle-mediated transport [GO:0060627]; epithelium development [GO:0060429]; canonical Wnt signaling pathway [GO:0060070]; Sertoli cell development [GO:0060009]; Sertoli cell differentiation [GO:0060008]; striated muscle cell development [GO:0055002]; muscle cell development [GO:0055001]; cellular response to stimulus [GO:0051716]; localization of cell [GO:0051674]; response to calcium ion [GO:0051592]; response to cAMP [GO:0051591]; response to glucocorticoid [GO:0051384]; establishment of localization [GO:0051234]; localization [GO:0051179]; striated muscle cell differentiation [GO:0051146]; positive regulation of cellular component organization [GO:0051130]; regulation of cellular component organization [GO:0051128]; positive regulation of transport [GO:0051050]; regulation of transport [GO:0051049]; positive regulation of secretion [GO:0051047]; regulation of secretion [GO:0051046]; leukocyte migration [GO:0050900]; response to stimulus [GO:0050896]; regulation of cellular process [GO:0050794]; regulation of biological process [GO:0050789]; cell motility [GO:0048870]; cellular developmental process [GO:0048869]; anatomical structure development [GO:0048856]; system development [GO:0048731]; myoblast development [GO:0048627]; reproductive structure development [GO:0048608]; response to steroid hormone [GO:0048545]; positive regulation of cellular process [GO:0048522]; positive regulation of biological process [GO:0048518]; animal organ development [GO:0048513]; cell development [GO:0048468]; secretion [GO:0046903]; response to organophosphorus [GO:0046683]; response to antibiotic [GO:0046677]; male sex differentiation [GO:0046661]; development of primary male sexual characteristics [GO:0046546]; positive regulation of exocytosis [GO:0045921]; myoblast differentiation [GO:0045445]; development of primary sexual characteristics [GO:0045137]; cellular lipid metabolic process [GO:0044255]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; positive regulation of cellular component biogenesis [GO:0044089]; regulation of cellular component biogenesis [GO:0044087]; cellular component biogenesis [GO:0044085]; macromolecule metabolic process [GO:0043170]; extracellular structure organization [GO:0043062]; muscle cell differentiation [GO:0042692]; response to hydrogen peroxide [GO:0042542]; response to drug [GO:0042493]; odontogenesis [GO:0042476]; response to chemical [GO:0042221]; wound healing [GO:0042060]; locomotion [GO:0040011]; tube development [GO:0035295]; response to cytokine [GO:0034097]; response to lipid [GO:0033993]; regulation of organelle organization [GO:0033043]; secretion by cell [GO:0032940]; regulation of localization [GO:0032879]; developmental process [GO:0032502]; multicellular organismal process [GO:0032501]; response to corticosteroid [GO:0031960]; epithelial cell differentiation [GO:0030855]; glycosaminoglycan metabolic process [GO:0030203]; cell differentiation [GO:0030154]; signaling [GO:0023052]; cellular component assembly [GO:0022607]; reproductive process [GO:0022414]; cytokine-mediated signaling pathway [GO:0019221]; regulation of exocytosis [GO:0017157]; cell migration [GO:0016477]; vesicle-mediated transport [GO:0016192]; diterpenoid metabolic process [GO:0016101]; Wnt signaling pathway [GO:0016055]; vesicle organization [GO:0016050]; cellular component organization [GO:0016043]; response to purine-containing compound [GO:0014074]; response to organic cyclic compound [GO:0014070]; positive regulation of organelle organization [GO:0010638]; response to organonitrogen compound [GO:0010243]; response to metal ion [GO:0010038]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; cellular process [GO:0009987]; tissue development [GO:0009888]; animal organ morphogenesis [GO:0009887]; response to hormone [GO:0009725]; response to endogenous stimulus [GO:0009719]; anatomical structure morphogenesis [GO:0009653]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; macromolecule biosynthetic process [GO:0009059]; biosynthetic process [GO:0009058]; macromolecule catabolic process [GO:0009057]; catabolic process [GO:0009056]; male gonad development [GO:0008584]; gonad development [GO:0008406]; metabolic process [GO:0008152]; biological_process [GO:0008150]; sex differentiation [GO:0007548]; multicellular organism development [GO:0007275]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; signal transduction [GO:0007165]; cell communication [GO:0007154]; organelle organization [GO:0006996]; response to oxidative stress [GO:0006979]; inflammatory response [GO:0006954]; defense response [GO:0006952]; response to stress [GO:0006950]; movement of cell or subcellular component [GO:0006928]; exocytosis [GO:0006887]; transport [GO:0006810]; nitrogen compound metabolic process [GO:0006807]; terpenoid metabolic process [GO:0006721]; isoprenoid metabolic process [GO:0006720]; lipid metabolic process [GO:0006629]; glycosaminoglycan catabolic process [GO:0006027]; aminoglycan catabolic process [GO:0006026]; glycosaminoglycan biosynthetic process [GO:0006024]; aminoglycan biosynthetic process [GO:0006023]; aminoglycan metabolic process [GO:0006022]; developmental process involved in reproduction [GO:0003006]; immune system process [GO:0002376]; epithelial cell development [GO:0002064]; mesonephros development [GO:0001823]; kidney development [GO:0001822]; ureteric bud development [GO:0001657]; urogenital system development [GO:0001655]; retinoid metabolic process [GO:0001523]; response to reactive oxygen species [GO:0000302]; reproduction [GO:0000003]","identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein binding [GO:0005515]; binding [GO:0005488]; molecular_function [GO:0003674]","extracellular vesicle [GO:1903561]; side of membrane [GO:0098552]; cell periphery [GO:0071944]; extracellular exosome [GO:0070062]; intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete plasma membrane part [GO:0044459]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete vacuolar part [GO:0044437]; obsolete Golgi apparatus part [GO:0044431]; obsolete membrane part [GO:0044425]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; obsolete extracellular region part [GO:0044421]; organelle lumen [GO:0043233]; intracellular membrane-bounded organelle [GO:0043231]; extracellular organelle [GO:0043230]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; lysosomal lumen [GO:0043202]; protein-containing complex [GO:0032991]; vesicle [GO:0031982]; membrane-enclosed lumen [GO:0031974]; intrinsic component of plasma membrane [GO:0031226]; intrinsic component of membrane [GO:0031224]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; endomembrane system [GO:0012505]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; Golgi lumen [GO:0005796]; Golgi apparatus [GO:0005794]; vacuolar lumen [GO:0005775]; vacuole [GO:0005773]; lysosome [GO:0005764]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; extracellular space [GO:0005615]; extracellular region [GO:0005576]; cellular_component [GO:0005575]; lytic vacuole [GO:0000323]",1,0,"P18828","","Upstream"
"RT21_HUMAN","P82921","28S ribosomal protein S21, mitochondrial",27,43,10,13.2,10.689,87,10.444,"MRPS21","MRPS21 RPMS21 MDS016"," "," ","X"," ","X"," "," ","X"," "," ","X"," "," "," "," ","X"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ","X","X"," "," "," "," ","X","X","X"," "," "," ","organic substance biosynthetic process [GO:1901576]; organonitrogen compound biosynthetic process [GO:1901566]; organonitrogen compound metabolic process [GO:1901564]; mitochondrial gene expression [GO:0140053]; cellular component organization or biogenesis [GO:0071840]; organic substance metabolic process [GO:0071704]; mitochondrial translational termination [GO:0070126]; mitochondrial translational elongation [GO:0070125]; cellular nitrogen compound biosynthetic process [GO:0044271]; cellular protein metabolic process [GO:0044267]; cellular macromolecule metabolic process [GO:0044260]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; protein-containing complex subunit organization [GO:0043933]; cellular protein complex disassembly [GO:0043624]; amide biosynthetic process [GO:0043604]; cellular amide metabolic process [GO:0043603]; macromolecule metabolic process [GO:0043170]; peptide biosynthetic process [GO:0043043]; cellular macromolecule biosynthetic process [GO:0034645]; cellular nitrogen compound metabolic process [GO:0034641]; protein-containing complex disassembly [GO:0032984]; mitochondrial translation [GO:0032543]; cellular component disassembly [GO:0022411]; protein metabolic process [GO:0019538]; cellular component organization [GO:0016043]; gene expression [GO:0010467]; cellular process [GO:0009987]; macromolecule biosynthetic process [GO:0009059]; biosynthetic process [GO:0009058]; metabolic process [GO:0008152]; biological_process [GO:0008150]; nitrogen compound metabolic process [GO:0006807]; peptide metabolic process [GO:0006518]; translational termination [GO:0006415]; translational elongation [GO:0006414]; translation [GO:0006412]","heterocyclic compound binding [GO:1901363]; organic cyclic compound binding [GO:0097159]; binding [GO:0005488]; structural molecule activity [GO:0005198]; structural constituent of ribosome [GO:0003735]; RNA binding [GO:0003723]; nucleic acid binding [GO:0003676]; molecular_function [GO:0003674]","ribonucleoprotein complex [GO:1990904]; mitochondrial protein complex [GO:0098798]; intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete mitochondrial part [GO:0044429]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; ribosomal subunit [GO:0044391]; organelle lumen [GO:0043233]; intracellular non-membrane-bounded organelle [GO:0043232]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; non-membrane-bounded organelle [GO:0043228]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; protein-containing complex [GO:0032991]; envelope [GO:0031975]; membrane-enclosed lumen [GO:0031974]; organelle envelope [GO:0031967]; mitochondrial membrane [GO:0031966]; organelle membrane [GO:0031090]; organelle inner membrane [GO:0019866]; membrane [GO:0016020]; small ribosomal subunit [GO:0015935]; ribosome [GO:0005840]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrial ribosome [GO:0005761]; mitochondrial matrix [GO:0005759]; mitochondrial inner membrane [GO:0005743]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]; organellar small ribosomal subunit [GO:0000314]; organellar ribosome [GO:0000313]"," ",NA," ",NA,NA,NA,"","Ribosomal protein S21 [IPR001911]; Ribosomal protein S21 superfamily [IPR038380]","9606.ENSP00000461930","Q9P0J6; P82912; P82675; Q92552; Q6P1L8; Q9P0M9; P82914; Q9Y676; Q96EY7; P82930; P82664; O60783; Q9Y3B7; P82932; Q9Y291; Q96EL2; Q96BP2; Q9BYN8; Q9Y3D3; P51398; Q92665; P82663; Q9Y2R9; Q9Y399; Q7Z7H8; Q96EL3; Q9H0U6; Q8TAE8; Q9P015; Q96A35; Q6P161; Q8N983; Q9NQ50; Q9Y3D5; Q9BQ48; P82673; Q8IXM3; Q8N5N7; Q9BYC9; Q9Y2R5","996; 994; 994; 993; 990; 990; 988; 988; 988; 988; 988; 987; 986; 985; 985; 985; 984; 983; 983; 983; 983; 983; 983; 982; 982; 982; 981; 981; 981; 980; 980; 979; 979; 979; 979; 979; 978; 977; 977; 977","organic substance biosynthetic process [GO:1901576]; organonitrogen compound biosynthetic process [GO:1901566]; organonitrogen compound metabolic process [GO:1901564]; mitochondrial gene expression [GO:0140053]; cellular component organization or biogenesis [GO:0071840]; organic substance metabolic process [GO:0071704]; mitochondrial translational termination [GO:0070126]; mitochondrial translational elongation [GO:0070125]; cellular nitrogen compound biosynthetic process [GO:0044271]; cellular protein metabolic process [GO:0044267]; cellular macromolecule metabolic process [GO:0044260]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; protein-containing complex subunit organization [GO:0043933]; cellular protein complex disassembly [GO:0043624]; amide biosynthetic process [GO:0043604]; cellular amide metabolic process [GO:0043603]; macromolecule metabolic process [GO:0043170]; peptide biosynthetic process [GO:0043043]; cellular macromolecule biosynthetic process [GO:0034645]; cellular nitrogen compound metabolic process [GO:0034641]; protein-containing complex disassembly [GO:0032984]; mitochondrial translation [GO:0032543]; cellular component disassembly [GO:0022411]; protein metabolic process [GO:0019538]; cellular component organization [GO:0016043]; gene expression [GO:0010467]; cellular process [GO:0009987]; macromolecule biosynthetic process [GO:0009059]; biosynthetic process [GO:0009058]; metabolic process [GO:0008152]; biological_process [GO:0008150]; nitrogen compound metabolic process [GO:0006807]; peptide metabolic process [GO:0006518]; translational termination [GO:0006415]; translational elongation [GO:0006414]; translation [GO:0006412]","heterocyclic compound binding [GO:1901363]; organic cyclic compound binding [GO:0097159]; binding [GO:0005488]; structural molecule activity [GO:0005198]; structural constituent of ribosome [GO:0003735]; RNA binding [GO:0003723]; nucleic acid binding [GO:0003676]; molecular_function [GO:0003674]","ribonucleoprotein complex [GO:1990904]; mitochondrial protein complex [GO:0098798]; intracellular organelle lumen [GO:0070013]; obsolete cell part [GO:0044464]; obsolete intracellular organelle part [GO:0044446]; obsolete cytoplasmic part [GO:0044444]; obsolete mitochondrial part [GO:0044429]; obsolete intracellular part [GO:0044424]; obsolete organelle part [GO:0044422]; ribosomal subunit [GO:0044391]; organelle lumen [GO:0043233]; intracellular non-membrane-bounded organelle [GO:0043232]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; non-membrane-bounded organelle [GO:0043228]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; protein-containing complex [GO:0032991]; envelope [GO:0031975]; membrane-enclosed lumen [GO:0031974]; organelle envelope [GO:0031967]; mitochondrial membrane [GO:0031966]; organelle membrane [GO:0031090]; organelle inner membrane [GO:0019866]; membrane [GO:0016020]; small ribosomal subunit [GO:0015935]; ribosome [GO:0005840]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrial ribosome [GO:0005761]; mitochondrial matrix [GO:0005759]; mitochondrial inner membrane [GO:0005743]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]; organellar small ribosomal subunit [GO:0000314]; organellar ribosome [GO:0000313]",1,0,"F1QKS9","","Downstream"
"PUS7L_HUMAN","Q9H0K6","Pseudouridylate synthase 7 homolog-like protein",23.6,43,4,16.3,80.7,701,7.294,"PUS7L","PUS7L"," ","X"," "," "," "," "," ","X"," "," "," "," "," "," ","X"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ","X"," "," "," "," "," "," "," "," ","X"," "," ","organic cyclic compound metabolic process [GO:1901360]; nucleic acid metabolic process [GO:0090304]; organic substance metabolic process [GO:0071704]; heterocycle metabolic process [GO:0046483]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; macromolecule modification [GO:0043412]; macromolecule metabolic process [GO:0043170]; cellular nitrogen compound metabolic process [GO:0034641]; RNA metabolic process [GO:0016070]; cellular process [GO:0009987]; RNA modification [GO:0009451]; metabolic process [GO:0008152]; biological_process [GO:0008150]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; nucleobase-containing compound metabolic process [GO:0006139]; pseudouridine synthesis [GO:0001522]","heterocyclic compound binding [GO:1901363]; organic cyclic compound binding [GO:0097159]; intramolecular transferase activity [GO:0016866]; isomerase activity [GO:0016853]; pseudouridine synthase activity [GO:0009982]; binding [GO:0005488]; catalytic activity [GO:0003824]; RNA binding [GO:0003723]; nucleic acid binding [GO:0003676]; molecular_function [GO:0003674]","obsolete cell part [GO:0044464]; obsolete intracellular part [GO:0044424]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]"," ",NA," ",NA,NA,NA,"","Pseudouridine synthase, catalytic domain superfamily [IPR020103]; Pseudouridine synthase, TruD [IPR001656]; Pseudouridine synthase, TruD, insertion domain [IPR011760]; Pseudouridine synthase, TruD, catalytic domain [IPR042214]","9606.ENSP00000415899","Q8TDN6; Q9NW13; Q9H0A0; Q9Y3T9; Q9Y606; Q5T953; Q96GQ7; Q9H7B2; Q8NI36; Q9GZL7; Q8WTT2; Q9NVU7; Q96D46; Q8WWH5; Q15397; Q9BQ67; Q12788; Q9BSC4; Q9H9Y6; P78316; Q9NY93; Q9GZR7; Q14692; Q13610; Q14137; Q969X6; O00567; Q9BZE4; Q9Y4C8; O00541; Q9UNX4; O95478; P42285; Q7L8W6; Q5JTH9; Q15061; Q8IWA0; Q8IY81; Q9BWM5; Q2NL82","734; 719; 717; 706; 697; 693; 691; 685; 684; 681; 677; 675; 672; 671; 670; 670; 669; 669; 667; 667; 666; 663; 663; 661; 655; 652; 651; 651; 650; 649; 648; 647; 647; 646; 645; 644; 641; 632; 631; 630","organic cyclic compound metabolic process [GO:1901360]; nucleic acid metabolic process [GO:0090304]; organic substance metabolic process [GO:0071704]; heterocycle metabolic process [GO:0046483]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; macromolecule modification [GO:0043412]; macromolecule metabolic process [GO:0043170]; cellular nitrogen compound metabolic process [GO:0034641]; RNA metabolic process [GO:0016070]; cellular process [GO:0009987]; RNA modification [GO:0009451]; metabolic process [GO:0008152]; biological_process [GO:0008150]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; nucleobase-containing compound metabolic process [GO:0006139]; pseudouridine synthesis [GO:0001522]","heterocyclic compound binding [GO:1901363]; organic cyclic compound binding [GO:0097159]; intramolecular transferase activity [GO:0016866]; isomerase activity [GO:0016853]; pseudouridine synthase activity [GO:0009982]; binding [GO:0005488]; catalytic activity [GO:0003824]; RNA binding [GO:0003723]; nucleic acid binding [GO:0003676]; molecular_function [GO:0003674]","obsolete cell part [GO:0044464]; obsolete intracellular part [GO:0044424]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]",1,1,"Q8CE46","Q8CE46","Downstream"
"TSR2_HUMAN","Q969E8","Pre-rRNA-processing protein TSR2 homolog",21.6,43,2,16.6,20.894,191,4.098,"TSR2","TSR2"," ","X"," "," "," "," "," ","X"," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," "," ","X"," "," ","organic cyclic compound metabolic process [GO:1901360]; nucleic acid metabolic process [GO:0090304]; cellular component organization or biogenesis [GO:0071840]; organic substance metabolic process [GO:0071704]; heterocycle metabolic process [GO:0046483]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; cellular component biogenesis [GO:0044085]; macromolecule metabolic process [GO:0043170]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; ncRNA metabolic process [GO:0034660]; cellular nitrogen compound metabolic process [GO:0034641]; ncRNA processing [GO:0034470]; maturation of SSU-rRNA [GO:0030490]; ribonucleoprotein complex biogenesis [GO:0022613]; rRNA metabolic process [GO:0016072]; RNA metabolic process [GO:0016070]; gene expression [GO:0010467]; cellular process [GO:0009987]; metabolic process [GO:0008152]; biological_process [GO:0008150]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; nucleobase-containing compound metabolic process [GO:0006139]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]","",""," ",NA," ",NA,NA,NA,"Diamond-Blackfan anemia 14, with mandibulofacial dysostosis (DBA14) [MIM:300946]: A form of Diamond-Blackfan anemia, a congenital non-regenerative hypoplastic anemia that usually presents early in infancy. Diamond-Blackfan anemia is characterized by a moderate to severe macrocytic anemia, erythroblastopenia, and an increased risk of malignancy. 30 to 40% of Diamond-Blackfan anemia patients present with short stature and congenital anomalies, the most frequent being craniofacial (Pierre-Robin syndrome and cleft palate), thumb and urogenital anomalies. {ECO:0000269|PubMed:24942156}. The disease is caused by mutations affecting the gene represented in this entry.","Pre-rRNA-processing protein TSR2 [IPR019398]","9606.ENSP00000364293","P62854; Q2NL82; Q9BVS4; Q13895; Q9NRX1; Q8NHQ9; Q9BQ67; Q13601; Q9Y221; Q9Y2X3; Q9UKD2; Q96GA3; Q9H7B2; Q9NVU7; Q99848; Q15050; Q9BYG3; Q9Y3A2; Q8N9T8; Q9GZS1; Q9NX24; Q96GQ7; Q8IY81; Q15061; O00541; Q9NYH9; O00567; Q8NEJ9; Q9Y3B9; Q3B726; Q8TDN6; O43818; Q9BXY0; Q9NY93; Q9UNX4; Q9UHA3; Q9Y6V7; Q5QJE6; Q9GZL7; Q96G21","987; 979; 951; 949; 936; 923; 919; 891; 886; 883; 882; 882; 880; 879; 877; 877; 877; 873; 865; 864; 858; 856; 856; 851; 851; 851; 849; 847; 847; 847; 846; 845; 843; 843; 842; 842; 842; 841; 841; 841","organic cyclic compound metabolic process [GO:1901360]; nucleic acid metabolic process [GO:0090304]; cellular component organization or biogenesis [GO:0071840]; organic substance metabolic process [GO:0071704]; heterocycle metabolic process [GO:0046483]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; cellular component biogenesis [GO:0044085]; macromolecule metabolic process [GO:0043170]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254]; ncRNA metabolic process [GO:0034660]; cellular nitrogen compound metabolic process [GO:0034641]; ncRNA processing [GO:0034470]; maturation of SSU-rRNA [GO:0030490]; ribonucleoprotein complex biogenesis [GO:0022613]; rRNA metabolic process [GO:0016072]; RNA metabolic process [GO:0016070]; gene expression [GO:0010467]; cellular process [GO:0009987]; metabolic process [GO:0008152]; biological_process [GO:0008150]; nitrogen compound metabolic process [GO:0006807]; cellular aromatic compound metabolic process [GO:0006725]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; nucleobase-containing compound metabolic process [GO:0006139]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]","","",0,0,"","","Downstream"
"SIAS_HUMAN","Q9NR45","Sialic acid synthase",7.6,43,1,5.5,40.308,359,6.421,"NANS","NANS SAS"," ","X",""," ","","","",""," ","","","","","","","",""," "," "," "," "," "," "," "," "," "," "," "," ",""," "," "," "," ",""," ","","",""," "," "," ","X","","","organic substance biosynthetic process [GO:1901576]; organic cyclic compound biosynthetic process [GO:1901362]; organic cyclic compound metabolic process [GO:1901360]; carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate derivative metabolic process [GO:1901135]; organic substance metabolic process [GO:0071704]; nucleobase-containing small molecule metabolic process [GO:0055086]; heterocycle metabolic process [GO:0046483]; CMP-N-acetylneuraminate metabolic process [GO:0046381]; small molecule metabolic process [GO:0044281]; cellular nitrogen compound biosynthetic process [GO:0044271]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; nucleobase-containing compound biosynthetic process [GO:0034654]; cellular nitrogen compound metabolic process [GO:0034641]; aromatic compound biosynthetic process [GO:0019438]; heterocycle biosynthetic process [GO:0018130]; carbohydrate biosynthetic process [GO:0016051]; cellular process [GO:0009987]; nucleotide-sugar biosynthetic process [GO:0009226]; nucleotide-sugar metabolic process [GO:0009225]; biosynthetic process [GO:0009058]; metabolic process [GO:0008152]; biological_process [GO:0008150]; nitrogen compound metabolic process [GO:0006807]; phosphorus metabolic process [GO:0006793]; cellular aromatic compound metabolic process [GO:0006725]; nucleobase-containing compound metabolic process [GO:0006139]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; carbohydrate metabolic process [GO:0005975]","cytidylyltransferase activity [GO:0070567]; N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444]; nucleotidyltransferase activity [GO:0016779]; transferase activity, transferring phosphorus-containing groups [GO:0016772]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; transferase activity [GO:0016740]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; catalytic activity [GO:0003824]; molecular_function [GO:0003674]","extracellular vesicle [GO:1903561]; extracellular exosome [GO:0070062]; obsolete cell part [GO:0044464]; obsolete cytoplasmic part [GO:0044444]; obsolete intracellular part [GO:0044424]; obsolete extracellular region part [GO:0044421]; extracellular organelle [GO:0043230]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; vesicle [GO:0031982]; cytosol [GO:0005829]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; extracellular space [GO:0005615]; extracellular region [GO:0005576]; cellular_component [GO:0005575]"," ",NA," ",NA,NA,NA,"Spondyloepimetaphyseal dysplasia, Genevieve type (SEMDG) [MIM:610442]: An autosomal recessive disorder characterized by global developmental delay with infantile onset, mental retardation, skeletal dysplasia, and short stature. Skeletal findings include flat vertebral bodies with irregular vertebral plates, irregular and flared metaphyses with vertical striations, small and irregular epiphyses, premature carpal ossification and small carpal bones. {ECO:0000269|PubMed:27213289}. The disease is caused by mutations affecting the gene represented in this entry.","Antifreeze-like/N-acetylneuraminic acid synthase C-terminal [IPR006190]; Antifreeze-like/N-acetylneuraminic acid synthase C-terminal domain superfamily [IPR036732]; Aldolase-type TIM barrel [IPR013785]; Antifreeze, type III [IPR006013]; N-acetylneuraminic acid synthase, N-terminal [IPR013132]; SAF domain [IPR013974]","9606.ENSP00000210444","Q8NFW8; Q9Y223; Q8TBE9; Q9BXD5; P51606; P00966; F6TLX2; Q96EP5; Q06830; O00625; P07954; Q6P587; Q96JF0; Q6ZXV5; P32119; P20962; P78382; P11717; Q8IVU1; Q99519; Q8IZF0; O15466; Q16842; Q8NDV1; Q11201; Q9H4F1; X6RH99; Q9UJ37; Q9UNP4; O60547; O95394; Q8TBP5; H0YEP7; Q9Y274; Q9BVH7; Q92185; P61647; O43173; Q9NSC7; Q96C23","996; 989; 970; 965; 941; 873; 870; 870; 822; 819; 819; 806; 779; 708; 687; 672; 669; 646; 627; 625; 624; 622; 617; 616; 615; 615; 613; 611; 609; 608; 604; 601; 600; 599; 599; 594; 594; 593; 590; 584","organic substance biosynthetic process [GO:1901576]; organic cyclic compound biosynthetic process [GO:1901362]; organic cyclic compound metabolic process [GO:1901360]; carbohydrate derivative biosynthetic process [GO:1901137]; carbohydrate derivative metabolic process [GO:1901135]; organic substance metabolic process [GO:0071704]; nucleobase-containing small molecule metabolic process [GO:0055086]; heterocycle metabolic process [GO:0046483]; CMP-N-acetylneuraminate metabolic process [GO:0046381]; small molecule metabolic process [GO:0044281]; cellular nitrogen compound biosynthetic process [GO:0044271]; cellular biosynthetic process [GO:0044249]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; nucleobase-containing compound biosynthetic process [GO:0034654]; cellular nitrogen compound metabolic process [GO:0034641]; aromatic compound biosynthetic process [GO:0019438]; heterocycle biosynthetic process [GO:0018130]; carbohydrate biosynthetic process [GO:0016051]; cellular process [GO:0009987]; nucleotide-sugar biosynthetic process [GO:0009226]; nucleotide-sugar metabolic process [GO:0009225]; biosynthetic process [GO:0009058]; metabolic process [GO:0008152]; biological_process [GO:0008150]; nitrogen compound metabolic process [GO:0006807]; phosphorus metabolic process [GO:0006793]; cellular aromatic compound metabolic process [GO:0006725]; nucleobase-containing compound metabolic process [GO:0006139]; CMP-N-acetylneuraminate biosynthetic process [GO:0006055]; carbohydrate metabolic process [GO:0005975]","cytidylyltransferase activity [GO:0070567]; N-acetylneuraminate synthase activity [GO:0050462]; N-acylneuraminate-9-phosphate synthase activity [GO:0047444]; nucleotidyltransferase activity [GO:0016779]; transferase activity, transferring phosphorus-containing groups [GO:0016772]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; transferase activity [GO:0016740]; N-acylneuraminate cytidylyltransferase activity [GO:0008781]; catalytic activity [GO:0003824]; molecular_function [GO:0003674]","extracellular vesicle [GO:1903561]; extracellular exosome [GO:0070062]; obsolete cell part [GO:0044464]; obsolete cytoplasmic part [GO:0044444]; obsolete intracellular part [GO:0044424]; obsolete extracellular region part [GO:0044421]; extracellular organelle [GO:0043230]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; vesicle [GO:0031982]; cytosol [GO:0005829]; cytoplasm [GO:0005737]; cell [GO:0005623]; intracellular [GO:0005622]; extracellular space [GO:0005615]; extracellular region [GO:0005576]; cellular_component [GO:0005575]",1,0,"Q99J77","","Downstream"
"UBQL2_HUMAN","Q9UHD9","Ubiquilin-2",4.7,43,1,3,65.696,624,5.033,"UBQLN2","UBQLN2 N4BP4 PLIC2 HRIHFB2157"," ","X",""," ","","","",""," ","","","","","","","",""," "," "," "," "," "," "," "," "," "," "," "," ",""," "," "," "," ",""," ","","",""," "," "," ","X","","","regulation of autophagosome assembly [GO:2000785]; regulation of clathrin-dependent endocytosis [GO:2000369]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; regulation of response to endoplasmic reticulum stress [GO:1905897]; autophagosome organization [GO:1905037]; positive regulation of ERAD pathway [GO:1904294]; regulation of ERAD pathway [GO:1904292]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; regulation of G protein-coupled receptor internalization [GO:1904020]; positive regulation of cellular protein catabolic process [GO:1903364]; regulation of cellular protein catabolic process [GO:1903362]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903069]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of proteolysis involved in cellular protein catabolic process [GO:1903050]; regulation of organelle assembly [GO:1902115]; positive regulation of proteasomal protein catabolic process [GO:1901800]; response to nitrogen compound [GO:1901698]; organic substance catabolic process [GO:1901575]; organonitrogen compound catabolic process [GO:1901565]; organonitrogen compound metabolic process [GO:1901564]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; import into cell [GO:0098657]; regulation of cellular response to stress [GO:0080135]; regulation of response to stress [GO:0080134]; regulation of primary metabolic process [GO:0080090]; clathrin-dependent endocytosis [GO:0072583]; cellular component organization or biogenesis [GO:0071840]; organic substance metabolic process [GO:0071704]; organelle assembly [GO:0070925]; biological regulation [GO:0065007]; process utilizing autophagic mechanism [GO:0061919]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of vesicle-mediated transport [GO:0060627]; regulation of macromolecule metabolic process [GO:0060255]; cellular response to stimulus [GO:0051716]; proteolysis involved in cellular protein catabolic process [GO:0051603]; positive regulation of protein metabolic process [GO:0051247]; regulation of protein metabolic process [GO:0051246]; establishment of localization [GO:0051234]; localization [GO:0051179]; positive regulation of nitrogen compound metabolic process [GO:0051173]; regulation of nitrogen compound metabolic process [GO:0051171]; negative regulation of cellular component organization [GO:0051129]; regulation of cellular component organization [GO:0051128]; negative regulation of transport [GO:0051051]; regulation of transport [GO:0051049]; response to stimulus [GO:0050896]; regulation of cellular process [GO:0050794]; regulation of biological process [GO:0050789]; negative regulation of response to stimulus [GO:0048585]; positive regulation of response to stimulus [GO:0048584]; regulation of response to stimulus [GO:0048583]; negative regulation of cellular process [GO:0048523]; positive regulation of cellular process [GO:0048522]; negative regulation of biological process [GO:0048519]; positive regulation of biological process [GO:0048518]; negative regulation of receptor-mediated endocytosis [GO:0048261]; regulation of receptor-mediated endocytosis [GO:0048259]; positive regulation of proteolysis [GO:0045862]; negative regulation of endocytosis [GO:0045806]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of protein catabolic process [GO:0045732]; cellular protein metabolic process [GO:0044267]; cellular macromolecule catabolic process [GO:0044265]; cellular macromolecule metabolic process [GO:0044260]; cellular protein catabolic process [GO:0044257]; cellular catabolic process [GO:0044248]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; regulation of vacuole organization [GO:0044088]; regulation of cellular component biogenesis [GO:0044087]; cellular component biogenesis [GO:0044085]; modification-dependent macromolecule catabolic process [GO:0043632]; macromolecule metabolic process [GO:0043170]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; receptor metabolic process [GO:0043112]; response to chemical [GO:0042221]; regulation of protein catabolic process [GO:0042176]; ERAD pathway [GO:0036503]; response to endoplasmic reticulum stress [GO:0034976]; cellular response to stress [GO:0033554]; regulation of organelle organization [GO:0033043]; regulation of localization [GO:0032879]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; positive regulation of cellular protein metabolic process [GO:0032270]; regulation of cellular protein metabolic process [GO:0032268]; receptor internalization [GO:0031623]; positive regulation of cellular catabolic process [GO:0031331]; regulation of cellular catabolic process [GO:0031329]; positive regulation of cellular metabolic process [GO:0031325]; negative regulation of cellular metabolic process [GO:0031324]; regulation of cellular metabolic process [GO:0031323]; ubiquitin-dependent ERAD pathway [GO:0030433]; protein catabolic process [GO:0030163]; regulation of proteolysis [GO:0030162]; regulation of endocytosis [GO:0030100]; adaptation of signaling pathway [GO:0023058]; negative regulation of signaling [GO:0023057]; positive regulation of signaling [GO:0023056]; signaling [GO:0023052]; regulation of signaling [GO:0023051]; cellular component assembly [GO:0022607]; negative adaptation of signaling pathway [GO:0022401]; modification-dependent protein catabolic process [GO:0019941]; protein metabolic process [GO:0019538]; regulation of metabolic process [GO:0019222]; regulation of macroautophagy [GO:0016241]; macroautophagy [GO:0016236]; vesicle-mediated transport [GO:0016192]; cellular component organization [GO:0016043]; negative regulation of cell communication [GO:0010648]; positive regulation of cell communication [GO:0010647]; regulation of cell communication [GO:0010646]; negative regulation of macromolecule metabolic process [GO:0010605]; positive regulation of macromolecule metabolic process [GO:0010604]; regulation of autophagy [GO:0010506]; proteasomal protein catabolic process [GO:0010498]; response to organonitrogen compound [GO:0010243]; response to organic substance [GO:0010033]; cellular process [GO:0009987]; negative regulation of signal transduction [GO:0009968]; positive regulation of signal transduction [GO:0009967]; regulation of signal transduction [GO:0009966]; positive regulation of catabolic process [GO:0009896]; regulation of catabolic process [GO:0009894]; positive regulation of metabolic process [GO:0009893]; negative regulation of metabolic process [GO:0009892]; macromolecule catabolic process [GO:0009057]; catabolic process [GO:0009056]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; metabolic process [GO:0008152]; biological_process [GO:0008150]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]; cell communication [GO:0007154]; vacuole organization [GO:0007033]; organelle organization [GO:0006996]; response to stress [GO:0006950]; autophagy [GO:0006914]; receptor-mediated endocytosis [GO:0006898]; endocytosis [GO:0006897]; transport [GO:0006810]; nitrogen compound metabolic process [GO:0006807]; ubiquitin-dependent protein catabolic process [GO:0006511]; proteolysis [GO:0006508]; negative regulation of receptor internalization [GO:0002091]; regulation of receptor internalization [GO:0002090]; G protein-coupled receptor internalization [GO:0002031]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; autophagosome assembly [GO:0000045]","modification-dependent protein binding [GO:0140030]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein binding [GO:0005515]; binding [GO:0005488]; molecular_function [GO:0003674]","intracellular vesicle [GO:0097708]; cell periphery [GO:0071944]; obsolete cell part [GO:0044464]; obsolete cytoplasmic part [GO:0044444]; obsolete intracellular part [GO:0044424]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; vesicle [GO:0031982]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cytosol [GO:0005829]; autophagosome [GO:0005776]; vacuole [GO:0005773]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]"," ",NA," ",NA,NA,NA,"Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia (ALS15) [MIM:300857]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. Patients with ALS15 may develop frontotemporal dementia. {ECO:0000269|PubMed:21857683, ECO:0000269|PubMed:22560112, ECO:0000269|PubMed:22717235, ECO:0000269|PubMed:22892309, ECO:0000269|PubMed:24215460, ECO:0000269|PubMed:25616961}. The disease is caused by mutations affecting the gene represented in this entry.","Armadillo-type fold [IPR016024]; STI1 domain [IPR041243]; Heat shock chaperonin-binding [IPR006636]; Ubiquitin-associated domain [IPR015940]; UBA-like superfamily [IPR009060]; Ubiquilin [IPR015496]; Ubiquilin-2 [IPR028430]; Ubiquitin-like domain [IPR000626]; Ubiquitin-like domain superfamily [IPR029071]","9606.ENSP00000345195","Q92783; P62987; P0CG48; P42566; Q96S82; P62979; P55036; P0CG47; Q9Y6I3; O95208; Q16186; Q96B97; O75886; O14964; P22681; P54725; Q9UBC2; P13569; Q2M2I8; P51809; Q13492; O60641; Q99962; Q9NY64; P02786; Q00610; Q99963; Q99961; P63010; P53675; Q8NFH8; P63027; P00533; Q9BV40; O75379; Q15836; Q9ULV1; P32121; P09496; P20645","985; 978; 965; 954; 952; 947; 945; 945; 938; 938; 936; 936; 933; 932; 927; 923; 923; 918; 914; 913; 912; 910; 909; 909; 909; 908; 908; 908; 907; 907; 907; 907; 907; 907; 907; 907; 906; 906; 905; 905","regulation of autophagosome assembly [GO:2000785]; regulation of clathrin-dependent endocytosis [GO:2000369]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; regulation of response to endoplasmic reticulum stress [GO:1905897]; autophagosome organization [GO:1905037]; positive regulation of ERAD pathway [GO:1904294]; regulation of ERAD pathway [GO:1904292]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; regulation of G protein-coupled receptor internalization [GO:1904020]; positive regulation of cellular protein catabolic process [GO:1903364]; regulation of cellular protein catabolic process [GO:1903362]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903069]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of proteolysis involved in cellular protein catabolic process [GO:1903050]; regulation of organelle assembly [GO:1902115]; positive regulation of proteasomal protein catabolic process [GO:1901800]; response to nitrogen compound [GO:1901698]; organic substance catabolic process [GO:1901575]; organonitrogen compound catabolic process [GO:1901565]; organonitrogen compound metabolic process [GO:1901564]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; import into cell [GO:0098657]; regulation of cellular response to stress [GO:0080135]; regulation of response to stress [GO:0080134]; regulation of primary metabolic process [GO:0080090]; clathrin-dependent endocytosis [GO:0072583]; cellular component organization or biogenesis [GO:0071840]; organic substance metabolic process [GO:0071704]; organelle assembly [GO:0070925]; biological regulation [GO:0065007]; process utilizing autophagic mechanism [GO:0061919]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of vesicle-mediated transport [GO:0060627]; regulation of macromolecule metabolic process [GO:0060255]; cellular response to stimulus [GO:0051716]; proteolysis involved in cellular protein catabolic process [GO:0051603]; positive regulation of protein metabolic process [GO:0051247]; regulation of protein metabolic process [GO:0051246]; establishment of localization [GO:0051234]; localization [GO:0051179]; positive regulation of nitrogen compound metabolic process [GO:0051173]; regulation of nitrogen compound metabolic process [GO:0051171]; negative regulation of cellular component organization [GO:0051129]; regulation of cellular component organization [GO:0051128]; negative regulation of transport [GO:0051051]; regulation of transport [GO:0051049]; response to stimulus [GO:0050896]; regulation of cellular process [GO:0050794]; regulation of biological process [GO:0050789]; negative regulation of response to stimulus [GO:0048585]; positive regulation of response to stimulus [GO:0048584]; regulation of response to stimulus [GO:0048583]; negative regulation of cellular process [GO:0048523]; positive regulation of cellular process [GO:0048522]; negative regulation of biological process [GO:0048519]; positive regulation of biological process [GO:0048518]; negative regulation of receptor-mediated endocytosis [GO:0048261]; regulation of receptor-mediated endocytosis [GO:0048259]; positive regulation of proteolysis [GO:0045862]; negative regulation of endocytosis [GO:0045806]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; positive regulation of protein catabolic process [GO:0045732]; cellular protein metabolic process [GO:0044267]; cellular macromolecule catabolic process [GO:0044265]; cellular macromolecule metabolic process [GO:0044260]; cellular protein catabolic process [GO:0044257]; cellular catabolic process [GO:0044248]; primary metabolic process [GO:0044238]; cellular metabolic process [GO:0044237]; regulation of vacuole organization [GO:0044088]; regulation of cellular component biogenesis [GO:0044087]; cellular component biogenesis [GO:0044085]; modification-dependent macromolecule catabolic process [GO:0043632]; macromolecule metabolic process [GO:0043170]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; receptor metabolic process [GO:0043112]; response to chemical [GO:0042221]; regulation of protein catabolic process [GO:0042176]; ERAD pathway [GO:0036503]; response to endoplasmic reticulum stress [GO:0034976]; cellular response to stress [GO:0033554]; regulation of organelle organization [GO:0033043]; regulation of localization [GO:0032879]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; positive regulation of cellular protein metabolic process [GO:0032270]; regulation of cellular protein metabolic process [GO:0032268]; receptor internalization [GO:0031623]; positive regulation of cellular catabolic process [GO:0031331]; regulation of cellular catabolic process [GO:0031329]; positive regulation of cellular metabolic process [GO:0031325]; negative regulation of cellular metabolic process [GO:0031324]; regulation of cellular metabolic process [GO:0031323]; ubiquitin-dependent ERAD pathway [GO:0030433]; protein catabolic process [GO:0030163]; regulation of proteolysis [GO:0030162]; regulation of endocytosis [GO:0030100]; adaptation of signaling pathway [GO:0023058]; negative regulation of signaling [GO:0023057]; positive regulation of signaling [GO:0023056]; signaling [GO:0023052]; regulation of signaling [GO:0023051]; cellular component assembly [GO:0022607]; negative adaptation of signaling pathway [GO:0022401]; modification-dependent protein catabolic process [GO:0019941]; protein metabolic process [GO:0019538]; regulation of metabolic process [GO:0019222]; regulation of macroautophagy [GO:0016241]; macroautophagy [GO:0016236]; vesicle-mediated transport [GO:0016192]; cellular component organization [GO:0016043]; negative regulation of cell communication [GO:0010648]; positive regulation of cell communication [GO:0010647]; regulation of cell communication [GO:0010646]; negative regulation of macromolecule metabolic process [GO:0010605]; positive regulation of macromolecule metabolic process [GO:0010604]; regulation of autophagy [GO:0010506]; proteasomal protein catabolic process [GO:0010498]; response to organonitrogen compound [GO:0010243]; response to organic substance [GO:0010033]; cellular process [GO:0009987]; negative regulation of signal transduction [GO:0009968]; positive regulation of signal transduction [GO:0009967]; regulation of signal transduction [GO:0009966]; positive regulation of catabolic process [GO:0009896]; regulation of catabolic process [GO:0009894]; positive regulation of metabolic process [GO:0009893]; negative regulation of metabolic process [GO:0009892]; macromolecule catabolic process [GO:0009057]; catabolic process [GO:0009056]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; metabolic process [GO:0008152]; biological_process [GO:0008150]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]; cell communication [GO:0007154]; vacuole organization [GO:0007033]; organelle organization [GO:0006996]; response to stress [GO:0006950]; autophagy [GO:0006914]; receptor-mediated endocytosis [GO:0006898]; endocytosis [GO:0006897]; transport [GO:0006810]; nitrogen compound metabolic process [GO:0006807]; ubiquitin-dependent protein catabolic process [GO:0006511]; proteolysis [GO:0006508]; negative regulation of receptor internalization [GO:0002091]; regulation of receptor internalization [GO:0002090]; G protein-coupled receptor internalization [GO:0002031]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; autophagosome assembly [GO:0000045]","modification-dependent protein binding [GO:0140030]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein binding [GO:0005515]; binding [GO:0005488]; molecular_function [GO:0003674]","intracellular vesicle [GO:0097708]; cell periphery [GO:0071944]; obsolete cell part [GO:0044464]; obsolete cytoplasmic part [GO:0044444]; obsolete intracellular part [GO:0044424]; intracellular membrane-bounded organelle [GO:0043231]; intracellular organelle [GO:0043229]; membrane-bounded organelle [GO:0043227]; organelle [GO:0043226]; vesicle [GO:0031982]; cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; plasma membrane [GO:0005886]; cytosol [GO:0005829]; autophagosome [GO:0005776]; vacuole [GO:0005773]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell [GO:0005623]; intracellular [GO:0005622]; cellular_component [GO:0005575]",1,0,"Q9QZM0","","Downstream"
